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He went to work when he'd spent his last dime
And Sammy took to stealing
When he got that empty feeling
For a hundred dollar habit without overtime.
And the gold rolled through his veins
Like a thousand railroad trains,
And eased his mind in the hours that he chose,
While the kids ran around wearin' other peoples' clothe ...
There's a hole in daddy's arm where all the money goes . ..
I. Introduction
Why are more than two and a half million Americans suffering
from substance use disorder ("SUD")? 2 Why did more than half a
million die from drug overdose from 1999-20153 and an estimated
72,000 in 2017 alone?4 Why do so few (maybe only 20%) of those
suffering from opioids use disorder ("OUD") receive treatment?s
Why do so many re-entering from prisons relapse and continue their
cycles of despair?' Should we be tackling a behavioral health services
problem, a substance use epidemic, an opioid epidemic or an opioid
overdose epidemic, or all of the above?
Sometimes, explanations to hard problems are found hiding
in plain sight. Recently, the academy lost Uwe Reinhardt, one of
the finest health policy scholars of his generation. Reinhardt, an
1 JOHN PRINE, Sam Stone, on JOHN PRINE (Atlantic Records 1971).
2 SUBSTANCE ABUSE & MENTAL HEALTH SERV. ADMIN. CTR. FOR
BEHAVIORAL HEALTH STATISTICS & QUALITY, RESULTS FROM THE 2016
NATIONAL SURVEY ON DRUG USE AND HEALTH: DETAILED TABLES 1220,
tbl.5.1A (2017), https://www.samhsa.gov/data/sites/default/files/NSDUH-
DetTabs-2016/NSDUH-DetTabs-2016.pdf.
3 Puja Seth et al., Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants
- United States, 2015-2016, 67 MORBIDITY & MORTALITY WKLY. REP. 349,
349 (2018).
4 Farida B. Ahmad et al., Provisional Drug Overdose Death Counts, NAT'L CTR. FOR
HEALTH STATISTICS (Nov. 14, 2018), https://www.cdc.gov/nchs/nvss/vsrr/
drug-overdose-data.htm.
5 See Olga Khazan, Why 80 Percent of Addicts Can't Get Treatment, THE ATLANTIC
(Oct. 13, 2015), https://www.theatlantic.com/health/archive/2015/10/why-
80-percent-of-addicts-cant-get-treatment/410269/.
6 Ingrid A. Binswanger et al., Return to Drug Use and Overdose After Release from
Prison: A Qualitative Study of Risk and Protective Factors, ADDICTION SCI. &
CLINICAL PRAC., Mar. 15, 2012, at 3, https://ascpjournal.biomedcentral.
com/track/pdf/10. 1186/1940-0640-7-3.
7 Sam Roberts, Uwe Reinhardt, 80, Dies; a Listened-to Voice on Health Care Policy,
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economist, wrote extensively about healthcare costs and in one
article famously concluded, "It's the prices, stupid!"' As we examine
the opioid crisis (and other diseases of despair), we should recognize
that here, also, there are some causes or accelerants hiding in plain
sight. Indeed, enough relate to healthcare access, financing, and
delivery that we should conclude, "It's the Healthcare, Stupid!"
In concentrating on the healthcare system, this article is
not seeking to oversimplify what is manifestly a wicked problem
with multiple, interlocking causes.' Specifically, nothing written
here should be misunderstood as minimizing the urgent need for
evidence-based harm-reducing public health interventions or denying
the fundamental role of social determinants of health upon which
addictions attach like parasites. Neither is this concentration on
healthcare simply a restatement of the evidence-based medicalization-
not-criminalization approach to the opioid crisis. Rather, the article
invites critical examination of our healthcare "system" seen through
an addictions frame; the way in which it supplies context and the
role it plays-or in many ways, fails to play-in crises generally and
specifically in the case of the opioid epidemic.
The article paints a picture of a healthcare system that not only
has been slow to deliver appropriate treatments but also stands as a
structural determinant of this crisis. Structural determinants create
barriers that stop or slow the remediation of social determinants
while perpetuating others. This paper argues that the healthcare
system has failed those struggling with OUD and co-morbidities
and is itself a structural determinant that creates barriers to effective
behavioral health services.
In some ways (such as poor preventative care and over-
prescribing) the healthcare system justifiably can be viewed as a
cause of the opioid epidemic. However, its true failing is the way it
has amplified the crisis; seemingly unable or unwilling to identify
appropriate points of intervention or deliver the necessary services.
The root causes of the opioid epidemic must be treated with
improved education, better surveillance, and generally addressing
N.Y. TiMES (Nov. 15, 2017), https://www.nytimes.com/2017/11/15/
obituaries/uwe-reinhardt-a-listened-to-voice-on-health-care-policy-dies-
at-80.html.
8 Gerard E Anderson et al., It's the Prices, Stupid: Why the United States is So Different
From Other Countries, 22 HEALTH AFFAIRS 89, 103 (2003).
9 See generally Jonathan C. Lee, The Opioid Crisis is a Wicked Problem, 27 AM. J. ON
ADDICTIONs 51, 51 (2017).
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the social determinants of health. However, the U.S. healthcare
system is responsible for many of the symptoms of the opioid crisis
and several of the barriers to effective solutions.
The article proceeds as follows. Section II provides context
for the current opioid crisis, identifying morphing drug sources
to shifting at-risk populations. Section III discusses social and
structural determinants of health, arguing that the healthcare
system is one of the latter. Section IV is a deeper dive into some
of healthcare's flaws relevant to this analysis, critically examining
access and benefit stratification, the changing role of Medicaid,
and problems associated with fragmentation of care and the lack
of wraparound services. Section V provides a brief overview of the
extreme healthcare-related structural determinants present in our
jails and prisons.
II. Inconvenient Truths
The public health (harm reduction) and medical (treatment)
frames for understanding disorders or addictions are widely
held. 10 However, many policymakers still cling to a "moral defect"
framing." Furthermore, although recognized by some as ineffective
or worse,12 many still believe in continuing or reviving the supply-
side criminalization seen in the "war on drugs." The opioid epidemic
also pushes some powerful psychological buttons; some of its causes
(drug over-prescription by physicians and misleading promotion
10 Scott Burris, Where Next for Opioids and the Law? Despair, Harm Reduction, Lawsuits,
and Regulatory Reform, 133 PUB. HEALTH REP. 29, 29-33 (2017); Nabarun
Dasgupta et al., Opioid Crisis: No Easy Fix to Its Social and Economic Determinants,
108 AM. J. OF PUB. HEALTH 182 (2018).
11 Nicole L. Henderson & William W Dressler, Medical Disease or Moral Defect?
Stigma Attribution and Cultural Models of Addiction Causality in a University
Population, 41 CULTURE, MED., & PSYCHIATRY 480, 492 (2017).
12 See, e.g., Mona Chalabi, The 'War on Drugs' in Numbers: A Systematic Failure of
Policy, THE GUARDIAN (Apr. 19, 2016), https://www.theguardian.com/
world/2016/apr/19/war-on-drugs-statistics-systematic-policy-failure-united-
nations; CHRISTOPHER J. COYNE & ABIGAIL R. HALL, CATO INSTITUTE,
FOUR DECADES AND COUNTING: THE CONTINUED FAILURE OF THE
WAR ON DRUGS (2017), https://object.cato.org/sites/cato.org/files/pubs/
pdf/pa-81 1-updated.pdf; Altaf Rahamatulla, The War on Drugs has failed. What's
next?, FORD FOUND. (Mar. 23, 2017), https://www.fordfoundation.org/
ideas/equals-change-blog/posts/the-war-on-drugs-has-failed-what-s-next/;
George P. Shultz & Pedro Aspe, The Failed War on Drugs, N.Y. TIMES (Dec. 31,
2017), https://www.nytimes.com/2017/12/31/opinion/failed-war-on-drugs.
html.
VOL. 11, No. 1 319
Terry
by pharmaceutical manufacturers) are identifiably blameworthy,1 3
sometimes leading to bad actors being shamed in front of
Congressional committees.14 And, at root there are, according to
the "moral defect" frame, junkies and their drug lords or kingpins,
although this crisis' kingpins are quite different from those seen
before."s
As befits a "'wicked' problem,"16 reality is somewhat more
complicated. An evolving view of the opioid use crisis is that there
exists not just one crisis, but two. Shanoor Seervai and colleagues
label the first as a "prescription-drug epidemic," typically impacting
older rural whites, but identify the second "emerging epidemic" as
impacting non-medical users (increasingly urban communities of
color) of heroin and fentanyl.17
The line drawn connecting these two epidemics is
controversial. The so-called "vector model" assigns causality to
drug users and suppliers-overprescribing leads to opioid abuse
and overdoses caused by whichever opiate is easiest to acquire." Of
course, the two crises (prescription and street drugs) are intertwined"
and it is not hard to conjure up a mental diagram illustrating how
changes in supply and prices of (frequently diverted) prescription
13 Barry Meier, 3 Executives Spared Prison in OxyContin Case, N.Y. TIMES (July 21,
2017), https://www.nytimes.com/2007/07/21/business/21pharma.html.
14 See Katie Zezima & Scott Higham, Drug Executives to Testify Before Congress About
Their Role in U.S. Opioid Crisis, WASH. POST (Apr. 12, 2018), https://www.
washingtonpost.com/national/drug-executives-to-testify-before-congress-
about-their-role-in-us-opioid-crisis/20 18/04/12/89e7ccf2-3db6- 11 e8-974f-
aacd97698cefstory.html?.
15 Esm6 E. Deprez et al., Deadly Chinese Fentanyl Is Creating a New Era of Drug
Kingpins, BLOOMBERG (May 22, 2018), https://www.bloomberg.com/news/
features/2018-05-22/deadly-chinese-fentanyl-is-creating-a-new-era-of-drug-
kingpins.
16 See generally Horst W J. Rittel & Melvin M. Webber, Dilemmas in a General Theory
of Planning, 4 POL'Y SCI. 155 (1973).
17 Shanoor Seervai et al., The U.S. Has Two Opioid Epidemics: The Federal Response
Should Consider Both, THE COMMONWEALTH FUND: TO THE POINT (Mar. 22,
2018), http://www.commonwealthfund.org/publications/blog/2018/mar/
federal-response-to-opioids.
18 See Dasgupta et al., supra note 10, at 183.
19 "And so it went. Oxycontin first, introduced by reps from Purdue Pharma over
steak and dessert and in air-conditioned doctors' offices. Within a few years,
black tar heroin followed in tiny uninflated balloons held in the mouths of
sugarcane farm boys from Xalisco driving old Nissan Sentras to meet-ups in
McDonald's parking lots." SAM QUINONES, DREAMLAND: THE TRUE TALE
OF AMERICA'S OPIATE EPIDEMIC 269 (2016).
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drugs lead to increases in the demand for street drugs.
However, the vector model for comprehending and reacting
to the opioid crises cannot stand.2 0 More closely examined, these
two increasingly diverging crises exhibit other and more complicated
similarities and differences. White middle-class persons with OUD
are more likely to have private insurance, unlike the rural and urban
poor, who are more likely to rely on Medicaid. Persons of color
are more likely to have been the subject of law enforcement and
face additional problems associated with societal re-entry from
corrections. Finally, and true to its internal (albeit flawed) logic,
the vector model emphasizes supply-side interventions such as
limitations on prescribing, 21 opioid reimbursement reforms, 22 and the
expansion of Prescription Drug Monitoring Programs ("PDMPs").23
Some of these reforms may impact the prescription drug epidemic. 24
However, they are likely to be of limited help regarding the second
epidemic and, obviously, do nothing to address underlying social
determinants of health.
A further inconvenience is that the nature of the problem
we face is hard to define or, even when defined, is muddied by
inconsistent labelling. According to The Diagnostic and Statistical
Manual of Mental Disorders ("DSM-5") "[t]he essential feature of
a substance use disorder is a cluster of cognitive, behavioral, and
physiological symptoms indicating that the individual continues
using the substance despite significant substance-related problems."2 5
Opioids are included in the list of substances. The core diagnostic
criterion for OUD is "[a] problematic pattern of opioid use leading
20 See Dasgupta et al., supra note 10 (rejecting "prescribing as the causative
vector" and arguing that economic and social upheaval are the primary
causes).
21 Deborah Dowell et al., CDC Guideline for Prescribing Opioids for Chronic Pain -
United States, 2016, 65 MORBIDITY & MORTALITY WKLY. REP. 1 (2018),
https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6501el.pdf.
22 See Dasgupta et al., supra note 10; see also 2019 Medicare Advantage and Part D
Advance Notice Part II andDraft Call Letter, CTRS. FOR MEDICARE & MEDICAID
SERVS. (Feb. 1, 2018), https://www.cms.gov/newsroom/fact-sheets/2019-
medicare-advantage-and-part-d-advance-notice-part-ii-and-draft-call-letter.
23 See generally Rebecca L. Haffajee et al., Mandatory Use of Prescription Drug
Monitoring Programs, 313 JAMA 891 (2015).
24 See generally Kelly K. Dineen, Addressing Prescription opioid Abuse Concerns in
Context: Synchronizing Policy Solutions to Multiple Complex Public Health Problems,
40 LAW & PSYCHOL. REV. 1 (2016).
25 AMERICAN PSYCHIATRIC ASSOCIATION, DIAGNOSTIC AND STATISTICAL
MANUAL OF MENTAL DISORDERS 483 (5th ed. 2013).
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to clinically significant impairment or distress." 26 Diagnosis of OUD
and its severity depends upon the presence of certain criteria, for
example " [r] ecurrent opioid use in situations in which it is physically
hazardous" or "[c]ontinued opioid use despite knowledge of having
a persistent or recurrent physical or psychological problem that is
likely to have been caused or exacerbated by substance. "27
Notwithstanding the discrete diagnosis of OUD, government
agencies such as the Substance Abuse and Mental Health Services
Administration ("SAMHSA') or the Centers for Medicare & Medicaid
Services ("CMS") tend not to break out OUD from SUD, tending
to refer more to the latter, although clearly accepting there is an
opioid epidemic. 28 When it comes to treatment, the broader phrase
"behavioral health services" often is employed referring to both
mental health and substance use disorder services. 29 The Affordable
Care Act ('ACA") uses the phrase "[m] ental health and substance use
disorder services, including behavioral health treatment" to define
one of its "essential health benefits." 30 The linkage to mental health
is not accidental. As noted in DSM-5, "[a]n important characteristic
of substance use disorders is an underlying change in brain circuits
that may persist beyond detoxification, particularly in individuals
with severe disorders."31 Finally, some refer to the current epidemic
as an opioid overdose crisis,3 2 a term that is both accurate and
perhaps telling in that overdoses, particularly overdose deaths, have
elevated this crisis in both public and political consciousnesses.3 3
In this article SUD will be used when describing a broader
addiction epidemic or when that language is used by agencies.
26 Id. at 541.
27 Id. In total DSM lists 11 such diagnostic/severity criteria.
28 See MEDICAID INNOVATION ACCELERATOR PROGRAM, infra note 211.
29 See, e.g., Behavioral Health Services, MEDICAID.Gov, https://www.medicaid.
gov/medicaid/benefits/bhs/index.html (last visited Dec. 9, 2018); see also
Behavioral Health Treatments and Services, SUBSTANCE ABUSE & MENTAL
HEALTH SERV. ADMIN. (Sept. 20, 2017), https://www.samhsa.gov/
treatment.
30 Patient Protection and Affordable Care Act, 42 U.S.C. § 18022(b) (1) (E)
(2018).
31 AM. PSYCHIATRIC AsS'N, supra note 25, at 483.
32 See, e.g., Opioid Overdose Crisis, NAT'L INST. ON DRUG ABUSE, https://www.
drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis (last updated
Mar. 2018).
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However, the article is concerned primarily with OUD, particularly at
the severe end of the scale involving opioid intoxication, withdrawal,
or overdose.3 4
Those definitional issues lead into another inconvenient
truth: that our current opioid epidemic is not unique. It is an
addiction crisis but is neither the only one we have faced nor likely
the last one we will face. Herzberg and colleagues have explained
how, at root, the opioid epidemic is part of an addiction problem that
stretches back over a century, with each crisis, (methamphetamine
in the 1980s, crack cocaine in the early 1990s, and so on) tending
to recycle "supply-side and criminal-justice approaches" rather than
"an expanded public health response."35 Until we solve the broader
addiction problem, we will be treating somewhat varying symptoms,
not root causes.
These root causes do require public health responses such
as improved education, better surveillance, and tackling social
determinants of health. However, many of the adverse symptoms of
the crisis (its co-morbidities if you like), and barriers to effective
solutions, should be laid at the feet of the U.S. healthcare system.
The opioid crisis does present as a "wicked problem,"36 however
"[e]very wicked problem can be considered to be a symptom of
another problem."3 7 On a daily basis, many of our fellow citizens
must confront problems with our healthcare system. Those with
OUD must deal with an amplified problem: a healthcare system that
is particularly poor at providing access to, or delivering appropriate
and necessary, healthcare services.
Ill. Structural Determinants and Overlapping Frames
Multiple frames are used to explain the opioids crisis. For
example, the linear (or vector) model begins with prescription
opioids and their over-prescription causing the crisis, followed by
some of the users transitioning over to illegal drugs as the supply
34 See AM. PSYCHIATRIC Ass'N, supra note 25, at 546-47; Ayman Fareed et al.,
Illicit opioid Intoxication: Diagnosis and Treatment, SUBSTANCE ABUSE: RES. &
TREATMENT, 2011, at 17.
35 David Herzberg et al., Recurring Epidemics ofPharmaceutical Drug Abuse in America:
Time for an All-Drug Strategy, 106 AM. J. PUB. HEALTH 408, 409 (2016).
36 Jonathan C. Lee, The Opioid Crisis isA Wicked Problem, 27AM.J. ON ADDICTIONS
51, 51 (2017).
37 Horst W.J. Rittel & Melvin M. Webber, Dilemmas in a General Theory of Planning,
4 POL'Y SCI. 155, 165 (1973).
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of prescription drugs is slowed.38 In fact, only 3.6% of prescription
opioid users transition to heroin, but 79.5% of heroin users previously
had used prescription opioids. 39 As already noted, concentrating on
supply fails to factor in the reasons for demand and tends to over-
focus interventions on the supply side.40
Increasingly, the opioids crisis has been identified as a "disease
of despair,"4 1 akin to the "deaths of despair" detailed by Anne Case
and Angus Deaton: an increase in mortality and morbidity among
non-Hispanic white Americans without college degrees caused in
part by "an increasingly difficult labor market." 42 Case and Deaton
themselves posit the view that "the prescription of opioids for
chronic pain added fuel to the flames, making the epidemic much
worse than it otherwise would have been."4 3 Dayna Matthew takes
a similar approach arguing, "social determinants contribute to
hopelessness and social trauma that 'set the stage' for opioid abuse
and dependency."4 4
Social determinants of health, the "complex, integrated,
and overlapping social structures and economic systems that are
responsible for most health inequities," are broadly and correctly
identified as causative with regard to diseases of despair including
the opioid crisis. Paula Braveman and colleagues define "health
38 See generally Dasgupta et al., supra note 10.
39 Pradip K. Muhuri et al., Associations of Nonmedical Pain Reliever Use and Initiation
of Heroin Use in the United States, CBHSQ DATA REV., Aug. 2013, at 2-3.
40 Dasgupta et al., supra note 10, at 182-83.
41 Jeff Guo, The Disease Killing White Americans Goes Way Deeper than Opioids, WAS H.
POST (Mar. 24, 2017), https://www.washingtonpost.com/news/wonk/
wp/2017/03/24/the-disease-killing-white-americans-goes-way-deeper-than-
opioids/?noredirect=on&utmterm=.734ce9f859c2; Michael Meit et al.,
Appalachian Diseases ofDespair, APPALACHIAN REGIONAL COMMI SSION (Aug.
2017), https://www.arc.gov/research/researchreportdetails.asp?REPORT_
ID= 139.
42 Anne Case & Angus Deaton, Mortality and Morbidity in the 21st Century, 2017
BROOKINGS PAPERS ON EcON. ACTIVITY 397, 399 [hereinafter Case &
Deaton, Mortality and Morbidity]; see also Anne Case & Angus Deaton, Rising
Morbidity and Mortality in Midlife Among White Non-Hispanic Americans in the 21st
Century, 112 PROC. NAT'L ACAD. Sci., Dec. 2015, at 15078 [hereinafter Case
& Deaton, Rising Morbidity].
43 Case & Deaton, Rising Morbidity, at 15078.
44 DAYNA BOWEN MATTHEW, UN-BURYING THE LEAD: PUBLIC HEALTH
TOOLS ARE THE KEY TO BEATING THE OPIOID EPIDEMIC 4 (2018),
https://www.brookings.edu/wp-content/uploads/2018/01/es_20180123
un-burying-the-lead-final.pdf.
45 NCHHSTP Social Determinants of Health, CTRS. FOR DISEASE CONTROL
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equity" as "the ethical and human rights principle that motivates
us to eliminate health disparities, which are differences in health or
its key determinants (such as education, safe housing, and freedom
from discrimination) that adversely affect marginalized or excluded
groups."4 6
Structural determinants include architectural, economic,
or political frameworks that create barriers to remediating social
determinants or perpetuate social determinants such as health
inequities. This paper argues that the healthcare system has failed
those struggling with OUD and co-morbidities and is itself a
structural determinant that creates barriers to effective behavioral
health services.
Flaws in the U.S. healthcare system are clearly not the
only structural determinants at play in the opioid crisis. As Dayna
Matthew notes, "[s]ocial determinants such as poor housing
conditions are often accompanied by neighborhood-level conditions
that limit access to health care, risk-reduction information, and
treatment alternatives, which are protective resources and can
disrupt behaviors that ultimately lead to opioid addiction." 7 A far
more specific example would be adverse policing practices in the
vicinity of syringe exchanges.
Two well-known frameworks may help to pinpoint the areas
where the healthcare system has failed the opioid epidemic. First, and
at a macro level, the Institute for Healthcare Improvement's Triple
Aim identifies the key goals of our healthcare system: "Improving
the patient experience of care (including quality and satisfaction);
Improving the health of populations; and Reducing the per capita
cost of health care."49
& PREVENTION, https://www.cdc.gov/nchhstp/socialdeterminants/
definitions.html (last updated Mar. 21, 2014); see e.g., Dasgupta et al., supra
note 10, at 182-86.
46 Paula Braveman et al., What Is Health Equity? And What Difference Does a Definition
Make?, ROBERT WOOD JOHNSON FOUND. 3 (May 2017), https://www.rwjf.
org/content/dam/farm/reports/issuebriefs/2017/rwjf437393 (emphasis
omitted).
47 MATTHEW, supra note 44.
48 See generally Leo Beletsky et al., Police Encounters Among Needle Exchange Clients in
Baltimore: Drug Law Enforcement as a Structural Determinant of Health, 105 AM. J.
PUB. HEALTH 1872 (2015).
49 The IHI Triple Aim, INST. FOR HEALTHCARE IMPROVEMENT, http://www.
ihi.org/Engage/Initiatives/TripleAim/Pages/default.aspx (last visited Dec. 8,
2018). See generally Donald M. Berwick et al., The Triple Aim: Care, Health, and
Cost, 27 HEALTH AFF. 759 (2008).
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Second, and at the micro opioid treatment level, SAMHSAs 0
and the American Society of Addiction Medicine ('ASAM") are
clear that the standard of care is comprised of the three Food and
Drug Administration-approved medication-assisted treatments
("MAT").s5 Additionally, ASAM recommends certain levels of
treatment services for those suffering from OUD: level 1 (outpatient
services), level 2 (intensive/partial hospitalization services), level
3 (residential/inpatient services), and level 4 (medically managed
intensive inpatient services).52
Failures and frequent barriers to effective interventions are as
rampant as they are obvious. At the macro level, they involve familiar
health policy tropes: limited access to care, high costs, and failures
in healthcare delivery. More specifically, our healthcare system is
not providing quality care to those with OUD, failing at the levels
of access and the standard of care. Population health (preventative
care and public health) continues to be put on a back burner
compared to expensive clinical interventions, such as surgery, and
our policymakers have completely missed the overwhelming cost-
benefit argument for preventative care and wraparound services for
those at OUD risk. At the micro level, MAT and appropriate levels
of treatment are still unavailable for vast swaths of the population.
Moreover, for some cohorts, such as rural populations and those in
jails and prisons, the level of neglect is extraordinary.
The healthcare system deserves to be called out as a
problem: primarily because of its role in causing the crisis and, more
importantly, because for so many affected by opioids the healthcare
system should have been a solution while in practice it has failed
them and frequently amplified their problems.
Foremost, the healthcare system must take some responsibility
for the opioids crisis. There is nothing new about opiate-based
treatment for pain; it dates back to the 19th century.5 3 However, in the
50 Medication Assisted Treatment (MAT), SAMHSA, https://www.samhsa.gov/
medication-assisted-treatment (last updated Feb. 7, 2018).
51 Information About Medication-Assisted Treatment (MAT), U.S. FOOD & DRUG
ADMIN., https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/
ucm600092.htm (last updated Oct. 3, 2018).
52 What are the ASAM Levels of Care?, ASAM CONTINUUM (May 13, 2015),
https://www.asamcontinuum.org/knowledgebase/what-are-the-asam-levels-
of-care. These levels of care are expanded upon at infra text accompanying
note 92.
53 See generally Marcia L. Meldrum, A Capsule History of Pain Management, 290
JAMA 2470 (2003).
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1990s clinicians were persuaded by the "non-addictive" marketing
of Oxycontin." Meanwhile, the greater expenses associated with
multidisciplinary approaches likely led to their disfavor among
providers and insurers, even though such methods can be highly
useful.ss Simultaneously, healthcare organizations were responsible
for designating pain as the "fifth vital sign"s6 and introducing pain
management into reimbursement-impacting patient satisfaction
scores. 57
Whatever the specific cause, there was a more liberal outlook
with regards to opioid prescribing, particularly for nonmalignant
pain.58 That prescribing trajectory continued almost as though the
2007 guilty pleas of Purdue Pharma, and three senior executives,
to accusations of misleading doctors never happened.59 As already
noted, the prescribing vector model for explaining the opioid crisis
is both flawed as to causation and tends to lead to over-reliance on
supply-side interventions.6 0 Notwithstanding this flawed hypothesis,
the healthcare system, together with those in the opioid prescription
drug supply chain, continues to deserve our disapprobation for doing
more to cause a problem than solve it.61
More fundamentally, the healthcare system has simply failed
those who need it most. Persons with SUD face acute problems
in accessing healthcare services. In 2016, 19.9 million adults
needed substance use treatment but only 10.8% received specialty
treatment; 26.9% of those who did not receive specialty treatment,
54 See QUINONES, supra note 19, at 124-27.
55 Id. at 86-87, 97-98; see also Marcia L. Meldrum, The Ongoing Opioid Prescription
Epidemic: Historical Context, 106 AM. J. PUB. HEALTH 1365 (2016) [hereinafter
Meldrum, Historical Context].
56 David W. Baker, History of The Joint Commission's Pain Standards: Lessons for Today's
Prescription opioid Epidemic, 317 JAMA 1117 (2017); see also Natalia E. Morone
& Debra K. Weiner, Pain as the 5th Vital Sign: Exposing the Vital Need for Pain
Education, 35 CLINICAL THERAPEUTICS 1728 (2013).
57 See generally Jay. S. Lee et al., Postoperative Opioid Prescribing and the Pain Scores
on Hospital Consumer Assessment of Healthcare Providers and Systems Survey, 317
JAMA 2013 (2017).
58 See id.; see also Meldrum, Historical Context, supra note 55, at 1365-66.
59 Barry Meier, In Guilty Plea, OxyContin Maker to Pay $600 Million, N.Y. TIMES
(May 10, 2007), https://www.nytimes.com/2007/05/1 0/business/1 Idrug-
web.html.
60 See Rittel, supra note 37.
61 See, e.g., Michael E. Schatman & Lynn R. Webster, The Health Insurance Industry:
Perpetuating the Opioid Crisis Through Policies of Cost-Containment and Profitability,
8 J. PAIN RES. 153, 155-56 (2015).
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but perceived that they did need it, cited no healthcare coverage
and not being able to afford the cost of treatment as reasons for
non-treatment.6 2 The history is plain to see, with the healthcare
system (from policymakers, to insurers, to healthcare institutions
and clinicians) failing those requiring behavioral healthcare services.
It was not until the 2008 passage of The Mental Health Parity and
Addiction Equity Act ("MHPAEA') 63 that health insurers had to
treat behavioral health benefits on a par with medical or surgical
benefits. The ACA64 continued its work by, for example, including
behavioral health as one of the statute's essential health benefits
("EHBs").6 s However, while there have been modest increases in
behavioral health spending,6 6 there have been numerous complaints
about its impact and, in particular, its enforcement. 7
Some of healthcare's failings are better understood as
fundamental systems problems. Nabarun Dasgupta and colleagues
catalog some of healthcare's failures: a system ill-equipped to
coordinate a combination of social and clinical ills, fragmentation
(and sometimes cessation) of care, limited access to MAT, and an
inability to provide wraparound services." Other issues that may
create barriers to treatment range from a lack of culturally competent
62 EUNICE PARK-LEE ET AL., SUBSTANCE ABUSE & MENTAL HEALTH SERV.
ADMIN., RECEIPT OF SERVICES FOR SUBSTANCE USE AND MENTAL
HEALTH ISSUES AMONG ADULTS: RESULTS FROM THE 2016 NATIONAL
SURVEY ON DRUG USE AND HEALTH (2017).
63 Emergency Economic Stabilization Act of 2008, Pub. L. 110-343, § 511, 122
Stat. 3765 (2008). See generally Implementation of the Mental Health Parity and
Addiction Equity Act (MHPAEA), SUBSTANCE ABUSE & MENTAL HEALTH
SERV. ADMIN., https://www.samhsa.gov/health-financing/implementation-
mental-health-parity-addiction-equity-act (last updated Jan. 24, 2017).
64 Patient Protection and Affordable Care Act, 42 U.S.C. § 180001 (2018).
65 Id. See generally Richard G. Frank et al., Behavioral Health Parity and the Affordable
CareAct, 13 J. SOC. WORK DISABILITY & REHABILITATION 31 (2015).
66 Sarah Friedman et al., The Mental Health Parity and Addiction Equity Act Evaluation
Study: Impact on Specialty Behavioral Healthcare Utilization and Spending Among
Enrollees with Substance Use Disorders, 80 J. SUBSTANCE ABUSE TREATMENT
67 (2017).
67 Jenny Gold, Advocates Say Mental Health 'Parity' Law is Not Fulfilling its Promise,
KAISER HEALTH NEWS (Aug. 3, 2015), https://khn.org/news/advocates-
say-mental-health-parity-law-is-not-fulfilling-its-promise/.
68 See Dasgupta et al., supra note 10, at 184. Wraparound services are considered
to be "non-clinical services that facilitate patient engagement and retention
in treatment as well as their ongoing recovery." U.S. DEP'T OF HEALTH &
HUMAN SERVS., OFFICE OF THE SURGEON GEN., FACING ADDICTION
IN AMERICA: THE SURGEON GENERAL'S REPORT ON ALCOHOL, DRUGS,
AND HEALTH 5-6 (2016).
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health services, or professionals, when dealing with the poor, the
addicted, or the mentally ill; to concerns about cost; the likelihood
of experiencing stigma; or even apprehension about sub-optimal
"care" that focuses on detox and potentially painful withdrawal."9
IV. Healthcare Structural Determinants Versus Opioid Responses
Most systems, be they industrial, technological, or social
services, are designed primarily to function for average use; to respond
to the mean. As a result, systems will experience outlying events
as stressors. Most will survive such an event, and some are even
capable of temporary ramp-ups to handle the outliers. However, the
U.S. healthcare ecosystem is uniquely fragile. In large part, because
it is not a single "system," it seems to have particular difficulties
responding to stressors whether they be pandemics, syndemics, or
natural disasters. For example, problems with healthcare delivery
were quite apparent in the aftermath of Hurricane Katrina and
during the Ebola outbreak.70
Structural barriers to healthcare access and delivery are
deeply seated and path dependent-even once-in-a-generation
major legislative and funding efforts, such as the ACA," only
make incremental changes to a system populated by persons and
institutions who lack incentives to change. The U.S. healthcare
system is not a particularly good one when measured against metrics
such as access, cost, or outcomes. 72 While it can excel at some tasks
69 Of course, this is something of an oversimplification. Barriers to treatment
are multiple, quite complicated, and include a lack of help-seeking behavior.
See, e.g., Philip W Appel et al., Barriers to Enrollment in Drug Abuse Treatment and
Suggestions for Reducing Them: Opinions of Drug Injecting Street Outreach Clients and
Other System Stakeholders, 30 AM. J. DRUG & ALCOHOL ABUSE 129 (2004).
70 See, e.g., Josh Voorhees, Everything That Went Wrong in Dallas: A Timeline of the
Many Missteps Surrounding the First Cases of Ebola Diagnosed in the United States,
SLATE (Oct. 16 2014), http://www.slate.com/articles/healthandscience/
medicalexaminer/2014/10/dallasebolatimelinethemanymedical_
misstepsattexashealthpresbyterian.html; Alyssa Rege, How Hurricane
Katrina Impacted Healthcare in New Orleans and What That May Mean for Houston,
BECKER'S Hosp. R. (Aug. 29, 2017), https://www.beckershospitalreview.
com/patient-flow/how-hurricane-katrina-impacted-healthcare-in-new-
orleans-and-what-that-may-mean-for-houston-5-takeaways.html.
71 Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 (2018).
72 See, e.g., Leah A. Burke & Andrew M. Ryan, The Complex Relationship Between
Cost and Quality in US Health Care, 16 AM. MED. Ass'N J. ETHICS 124, 127
(2014); Cynthia Cox & Bradley Sawyer, How Does Cost Affect Access to Care?,
KAISER FAMILY FOUND.: PETERSON-KAISER HEALTH SYSTEM TRACKER
(Jan. 17, 2018), https://www.healthsystemtracker.org/chart-collection/cost-
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such as complex surgeries, its strength does not lie in diagnostics or
treating chronic illnesses7 3-areas of great need for those with OUD.
The U.S. healthcare system's major operational deficiencies are well
known. For example, the U.S. spends more on its healthcare than any
other economically advanced country yet receives less both in terms
of the percentage of the population receiving care and the quality
of the care provided. The list of symptoms and causative factors
is long and includes: access problems (particularly for the poor
and the near poor), high and increasing costs (including insurance
costs, prescription drug costs, and cost-shifting), substandard care
coordination, a frequently incoherent healthcare delivery model
involving multiple types of entities and or reimbursement models,
and severe deficiencies in data management and sharing.75 These,
among many others, are architectural, financing, or implementation
flaws that have presented as barriers to effective responses to the
opioid crisis.
This article concentrates on only a few of the myriad defects
in our healthcare system; those that play out with particular force
in the context of the opioid crisis. First, the difficulty of access to
healthcare services is illustrated by examining the stratified manner
in which persons are provided access to healthcare insurance:
the gateway to healthcare in the U.S. Second, and closely related
to the first, is the recent whiplash phenomenon associated with
Medicaid, the insurance system arguably best positioned to provide
preventative care and treatment for those susceptible to diseases
of despair but which increasingly is beginning to act more like a
problem than a solution. Third, behavioral and non-behavioral
health disciplines have developed with differential architectures,
both as to treatment models, locations, and data sharing-defects
that highlight the healthcare system's fundamental inability to
provide care coordination and wraparound services.
affect-access-care/.
73 See, e.g., U.S. Spends More on Health Care Than Other High-Income Nations but has
Lower Life Expectancy, Worse Health, COMMONWEALTH FUND (Oct. 8, 2015),
http://www.commonwealthfund.org/publications/press-releases/2015/oct/
us-spends-more-on-health-care-than-other-nations.
74 See id.; Melissa Etehad & Kyle Kim, The U.S. Spends More on Healthcare ThanAny
Other Country-But Not with Better Health Outcomes, L.A. TIMES (July 28, 2017),
https://www.latimes.com/nation/la-na-healthcare-comparison-20170715-
htmlstory.html.
75 See Nicolas R Terry, Pit Crews with Computers: Can Health Information Technology
Fix Fragmented Care?, 14 HousToN J. HEALTH L. & POL'Y 132 (2014).
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A. The Standard of Care
The ideal treatment of addiction is to "address the needs of
the whole person," selecting from a menu of services.76 Although
detoxification and recovery models, such as 12-step programs, are
used in the OUD space, the standard of care for severe OUD is
MAT,7 the use of FDA-approved medications in combination with
counseling, and behavioral therapies.78 Although more treatment
modes are promised, currently there are three: those using
methadone, buprenorphine, or naltrexone.
While all three modes are generally safe, and reduce the risk
of overdose, they differ in their chemical effects and, as a result, the
conditions imposed on their delivery. 0 As to the former, methadone
is an agonist, buprenorphine a partial agonist, and naltrexone is an
antagonist." These labels describe how closely their chemical effects
resemble or mimic opioids; an agonist essentially tricks the brain
into thinking there is an opioid present (by reducing cravings and
delaying withdrawal), while an antagonist blocks an opioid from
76 Drugs, Brains, and Behavior: The Science of Addiction, NAT'L INST. ON DRUG
ABUSE, https://www.drugabuse.gov/publications/drugs-brains-behavior-
science-addiction/treatment-recovery (last updated July 2018).
77 Nora D. Volkow et al., Medication-Assisted Therapies - Tackling the opioid-
Overdose Epidemic, 370 NEw ENG. J. MED. 2063 (2014); see also Drugs, Brains,
and Behavior: The Science of Addiction, supra note 76 ("Research shows that
when treating addictions to opioids (prescription pain relievers or drugs like
heroin or fentanyl), medication should be the first line of treatment, usually
combined with some form of behavioral therapy or counseling.").
78 Medication-Assisted Treatment (MAT), SUBSTANCE ABUSE AND MENTAL
HEALTH SERV. ADMIN., https://www.samhsa.gov/medication-assisted-
treatment (last updated Feb. 7, 2018); see also CDER Conversation: Treatment for
Opioid UseDisorder, U.S. FOOD & DRUG ADMIN. (July28, 2018), https://www.
fda.gov/Drugs/NewsEvents/ucm611659.htm. See generally Kate Sheridan,
How Effective is Medication-Assisted Treatment for Addiction? Here's the Science,
STATNEWS (May 15, 2017), https://www.statnews.com/2017/05/15/
medication-assisted-treatment-what-we-know/.
79 Press release, U.S. FDA, FDA Takes New Steps to Encourage the Development
of Novel Medicines for the Treatment of Opioid Use Disorder (Aug. 6, 2018),
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/
ucm615892.htm.
80 Sheridan, supra note 78.
81 CATHIE E. ALDERKS, SUBSTANCE ABUSE AND MENTAL HEALTH SERV.
ADMIN., TRENDS IN THE USE OF METHADONE, BUPRENORPHONE, AND
EXTENDED-RELEASE NALTREXONE AT SUBSTANCE ABUSE TREATMENT
FACILITIES: 2003-2015 1 (Aug. 22, 2017), https://www.samhsa.gov/data/
sites/default/files/report_3192/ShortReport-3 192.pdf.
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having any effect on the brain.8 2 While the agonists, methadone and
buprenorphine, are chemically related to opioids, the antagonist
naltrexone is not opioid-based83 (and so unlikely to be the subject of
diversion).
SAMHSA requires that methadone only be dispensed
through an opioid treatment program ("OTP") accredited by a
"federally deemed accrediting body,"8 4 while physicians who have
obtained a Drug Enforcement Administration waiver, which requires
buprenorphine-specific training, may prescribe buprenorphine,s
and any licensed provider can prescribe naltrexone. 6 Patients
should be evaluated to determine the most appropriate individual
treatment, typically using the ASAM clinical guidelines. 7 Methadone
is associated with robust long-term recovery but must be carefully
calibrated and is prone to abuse or diversion, 8 while naltrexone
should not be administered before full opioid withdrawal." There
is also some evidence that buprenorphine is superior to methadone
for use by pregnant women, as fetal outcomes are slightly better. 0
Different clinical states of patients and their different contexts
influence the choice of drug and emphasizes that the standard of
82 Sheridan, supra note 78; see also Medication-Assisted Treatment: Naltrexone,
SUBSTANCE ABUSE AND MENTAL HEALTH SERV. ADMIN., https://www.
samhsa.gov/medication-assisted-treatment/treatment/naltrexone (last
visited Dec. 18, 2018).
83 Medication-Assisted Treatment (MAT), supra note 78.
84 For background on the accreditation process see Opioid Treatment Program (OTP)
Accreditation, JoINT COMM'N (Nov. 14, 2018), https://www.jointcommission.
org/factsopioidtreatment program-otp accreditation/.
85 See generally Medication-Assisted Treatment: Buprenorphine Waiver Management,
SUBSTANCE ABUSE AND MENTAL HEALTH SERV. ADMIN., https://www.
samhsa.gov/programs-campaigns/medication-assisted-treatment/training-
materials-resources/buprenorphine-waiver (last updated Jan. 18, 2018).
86 Medication-Assisted Treatment: Naltrexone, supra note 82.
87 Kyle Kampman & Margaret Jarvis, American Society ofAddiction Medicine National
Practice Guideline for the Use of Medications in the Treatment of Addiction Involving
Opioid Use, 9(5) J. OF ADDICTION MED. 358 (2015).
88 How effective are medications to treat opioid use disorder?, NAT'L INST. DRUG
ABUSE (June 2018), https://www.drugabuse.gov/publications/research-
reports/medications-to-treat-opioid-addiction/efficacy-medications-opioid-
use-disorder. See generally Herbert D. Kleber, Pharmacologic Treatments for Opioid
Dependence: Detoxification and Maintenance Options, 9 DIALOGUES CLINICAL
NEUROSCIENCE 455 (2007).
89 Medication-Assisted Treatment: Naltrexone, supra note 82.
90 Barbara K. Zedler, et al., Buprenorphine Compared with Methadone to Treat Pregnant
Women with opioid Use Disorder: A Systematic Review and Meta-Analysis of Safety in
the Mother, Fetus and Child, 111 ADDICTION 2115 (2016).
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care requires the availability of all three forms of MAT.
Assessment of the recommended levels of care increasingly
also is performed by reference to ASAM guidelines. In general, Level
1 refers to outpatient services; Level 2 intensive outpatient services;
Level 3 residential inpatient services; and Level 4 intensive inpatient
services. 1 ASAM also recognizes additional point levels. These
include Level 0.5 (early intervention), 2.5 (partial hospitalization
service), and 3.5 (clinically-managed, high-intensity residential
services for adults and medium-intensity for adolescents).92
The standard of care notwithstanding, there are some very
obvious examples of structural determinants (and not only in jails
and prisons where the standard of care seldom is met). Across the
nation, there are a limited number of OTPs certified by SAMHSA,
with a few states having none,9 3 while there are state variations in
the number of providers who have applied for the buprenorphine
waiver.14
B. Stratification and Benefit Indeterminacy
If educational, physical, and economic environments are
social determinants of health, then limited access, high costs,
and insufficient (limited or poor quality) services are structural
determinants. Those with OUD are disproportionately represented
in the cohorts without access or faced with social, financial,
demonstrative, geographical, or other barriers to health." These
barriers are caused or exacerbated not only by the barriers intrinsic to
each stratum (e.g., eligibility, cost-sharing, etc.) but also by the very
fact of stratification. The root causes of this stratification are decisions
that were made during the Second World War that linked healthcare
91 E. Chuang et al., Factors Associated with Use ofASAM Criteria and Service Provision
in a National Sample of outpatient substance Abuse Treatment Units, 3 J. ADDICTION
MED. 139 (2009).
92 What are the ASAMLevels of Care?, CONTINUUM: ASAM CRITERIA DECISION
ENGINE (May 13, 2015), https://www.asamcontinuum.org/knowledgebase/
what-are-the-asam-levels-of-care/.
93 Opioid Treatment Program Directory, SUBSTANCE ABUSE AND MENTAL
HEALTH SERVS. ADMIN., https://dpt2.samhsa.gov/treatment/directory.aspx
(last visited Jan. 27, 2019).
94 Number ofDATA-Waived Practitioners Newly Certified Per Year, SUBSTANCE ABUSE
& MENTAL HEALTH SERVS. ADMIN., https://www.samhsa.gov/medication-
assisted-treatment/treatment (last visited Jan. 27, 2019).
95 Kenneth A. Feder et al., Trends in Insurance Coverage and Treatment Among Persons
with Opioid Use Disorders Following the Affordable Care Act, 179 DRUG & ALCOHOL
DEPENDENCE 271 (2017).
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to health insurance and health insurance to employment."6 Writing
before the ACA, Atul Gawande noted the path-dependence that has
resulted.17 Today, employer-provided private coverage remains our
gold standard, with the constructs, such as managed care, designed
to keep it afloat occasionally migrating to public insurance. Worse,
health insurance provided outside of that idealized private scenario
is viewed as suspect and increasingly as exceptional rather than a
foundation on which to embrace and build universality. And, most
sadly, the association of health insurance with employment has led
to some embracing the perverse mission of curtailing Medicaid for
those not working."8 While many with OUD work, a large minority
of them do not have access to the gold standard of employer group
coverage," the Medicaid that so many rely on is under political
attack, 100 and their very eligibility for public health insurance may be
at risk because of emerging administrative and work requirements. 101
1. Differentially-Treated Cohorts
Stratification tends to be based on income (or the lack thereof)
expressed in terms of relative variance from the Federal Poverty Level
("FPL").102 As these vary, beneficiaries on the edge of the qualification
tiers may experience churn between types of insurance, exacerbating
indeterminacy of insurance and so healthcare. 103 There may also be a
political cost. Persons on the margins of what are, after all, arbitrary
eligibility dividing lines between coverages with different benefits
96 See Dan Gorenstein, How Did We End Up with Health Insurance Being Tied to Our
Jobs?, MARKETPLACE (June 28, 2017, 4:00 PM), https://www.marketplace.
org/2017/06/28/health-care/how-did-we-end-health-insurance-being-tied-
our-jobs.
97 Atul Gawande, Getting Therefrom Here, NEW YORKER: ANNALS PUB. POL'Y,
(Jan. 26, 2009), https://www.newyorker.com/magazine/2009/01/26/getting-
there-from-here.
98 See infra text accompanying note 172.
99 The NSDUH Report, SUBSTANCE ABUSE AND MENTAL HEALTH SERVS.
ADMIN. (Aug. 7. 2014), https://www.samhsa.gov/data/sites/default/files/
NSDUH-SP132-FullTime-2014/NSDUH-SP132-FullTime-2014.pdf.
100 See discussion infra Section C.
101 Sara Rosenbaum, Stewart v. Azar and the Future of Medicaid Work Requirements,
COMMONWEALTH FUND (July 3, 2018), https://www.commonwealthfund.
org/future-of-Medicaid-work-requirements.
102 See generally Federal Poverty Level, HEALTHCARE.Gov, https://www.healthcare.
gov/glossary/federal-poverty-level-fpl/ (last visited Dec. 16, 2018).
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or premiums, may feel animosity to cohorts "treated better" on the
other side of a cut-off (e.g., someone at 200 FPL comparing their
premiums with those in the Medicaid expansion cohort).104
For decades, access to health insurance has been the key to
access to healthcare in the U.S. 10s Those who cannot afford insurance
are often denied access to healthcare. 106 Notwithstanding the
reforms introduced by the ACA, 15.5% of those of working-age
remain uninsured.10 7 Those most at risk of being uninsured are
those with low-income and people of color.108 Although the majority
of nonelderly adults with opioid addiction are employed, 109 they
likely have low incomes and are therefore less likely than adults
with higher incomes to have employer-provided health insurance.
Approximately 10% are unemployed and 13% are disabled, and as a
group they tend to suffer from comorbidities. 110
When the Supreme Court in NFIB v. SebeliusI rendered
Medicaid expansion voluntary for the states, it opened up another
cleavage in access to healthcare, one based on the accident of state
of residence. Over two million of the uninsured cohort lack health
insurance because their states of residence (primarily in the south
and, typically, correlating with poor social determinants) have
decided to forego Medicaid expansion.112
104 See Louise Norris, The ACA's Cost-Sharing Subsidies, HEALTHINSURANCE.ORG
(Dec. 11, 2018), https://www.healthinsurance.org/obamacare/the-acas-cost-
sharing-subsidies/.
105 See generally CHRISTY FORD CHAPIN, ENSURING AMERICA'S HEALTH: THE
PUBLIC CREATION OF THE CORPORATE HEALTH CARE SYSTEM (2017).
106 See generally BEATRIX HOFFMAN, HEALTH CARE FOR SOME: RIGHTS AND
RATIONING IN THE UNITED STATES SINCE 1930 (2012).
107 Sara R. Collins et al., First Look at Health Insurance Coverage in 2018 Finds ACA
Gains Beginning to Reverse, COMMONWEALTH FUND: TO THE POINT (May 1,
2018), https://www.commonwealthfund.org/blog/2018/first-look-health-
insurance-coverage-2018-finds-aca-gains-beginning-reverse.
108 JULIA FOUTZ ET AL., The Uninsured: A Primer 1 (2017), http://files.kff.
org/attachment/Report-The- Uninsured-A-Primer-Key-Facts-about-Health-
Insurance-and-the-Uninsured-Under-the-Affordable-Care-Act.
109 NSDUH Report, supra note 99.
110 Julia Zur & Jennifer Tolbert, The opioid Epidemic and Medicaid's Role in Facilitating
Access to Treatment, KFF (Apr. 11, 2018), https://www.kff.org/medicaid/
issue-brief/the-opioid-epidemic-and-medicaids-role-in-facilitating-access-to-
treatment/.
111 NFIB v. Sebelius, 567 U.S. 519, 585 (2012).
112 Rachel Garfield et al., The Coverage Gap: Uninsured Poor Adults in States that Do
Not Expand Medicaid, KFF (June 12, 2018), https://www.kff.org/medicaid/
issue-brief/the-coverage-gap-uninsured-poor-adults-in-states-that-do-not-
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In the stratified world of health insurance (and so of access
to healthcare), the first stratum to recognize is the uninsured. Being
uninsured does not preclude all access to healthcare. However, safety-
net care such as emergency department access courtesy of Emergency
Medical Treatment & Labor Act ("EMTALA") 113 only provides
emergency care, not the preventative or chronic care necessary to
identify or treat addictions.114 As Julia Foutz and colleagues express
the issue: "[h]ealth insurance makes a difference in whether and
when people get necessary medical care, where they get their care,
and ultimately, how healthy they are. Uninsured people are far more
likely than those with insurance to postpone health care or forgo it
altogether."11 s
Insured versus uninsured status is not a simple binary. The
uninsured cohort is relatively cohesive; there may be some wealthy
persons who forego insurance, but the overwhelming majority of the
uninsured cohort are poor, likely suffering from one or more diseases
of despair, and highly unlikely to have access to OUD treatment
within the standard of care.116
In contrast, the insured are highly stratified. The largest
stratum (approximately 50% of those with health insurance)117
consists of those whose insurance is provided by their employer. In
most cases their insurance will provide behavioral health coverage
and therefore likely paths to treatment and recovery.' However, as
the President's Commission recognized, "[t]here are commercial
expand-medicaid/; see also Fredric Blavin et al., Medicaid Versus Marketplace
Coverage For Near-Poor Adults: Effects On Out-Of-Pocket Spending And Coverage, 37
HEALTH AFF. 299 (2018).
113 Social Security Act of 1935 § 1867, 42 U.S.C. § 1395 (2018).
114 See Sawyer, N. T., Why the EMTALA Mandate for Emergency Care Does not Equal
Healthcare "Coverage", 18 WESTERN J. EMERGENCY MED. 551, 551-52
(2017).
115 FouTz, supra note 108.
116 Feder, supra note 95. See also Li-Tzy Wu et al., Treatment Utilization Among
Persons with Opioid Use Disorder in the United States, 169 DRUG & ALCOHOL
DEPENDENCE 117 (2016); Praise 0. Iyiewuare et al., Demographic and Mental
Health Characteristics of Individuals Who Present to Community Health Clinics with
Substance Misuse, 4 HEALTH SERV. RES. & MANAGERIAL EPIDEMIOLOGY 1
(2017).
117 HENRYJ. KAISER FAMILY FOUNDATION, HEALTH INSURANCE COVERAGE
OF THE TOTAL POPULATION (2017), https://www.kff.org/other/state-
indicator/total-population/?.
118 Jessica M. Harwood et al., The Mental Health Parity and Addiction Equity Act
Evaluation Study, 55 MED. CARE 164 (2017).
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insurance barriers to MAT, such as dangerous fail-first protocols
and onerous and frequent prior authorization requirements.""'
Additionally, this predominantly white, middle class group will
find their treatment restricted in similar ways to the rest of their
healthcare, with limits on types and days of care and massive cost
shifting when using out-of-network care1 2 0 (a real likelihood given
the dearth of opioid treatment providers). Looking forward, the
actuarial value of employer-provided coverage is in steep decline,
creating a new stratum-the underinsured-who increasingly
cannot afford to undertake their insured treatment or care because
of high deductibles or other cost-shifting. 12 1
Outside of employer-provided group coverage the insured
generally fall into one of four health insurance cohorts: Medicare,
Medicaid, Expanded Medicaid, or the Exchange Marketplaces. 12 2 Of
these, Medicare has the greatest access to OUD care with the fewest
barriers. Medicare enrollees, the elderly and near-elderly, do not
immediately seem to fit the OUD demographic. However, they make
up about 25% of long-term opioid users1 23 and are among the fastest
growing population with diagnosed OUD. 12 4
119 GOVERNOR CHRIS CHRISTIE ET AL., THE PRESIDENT'S COMMISSION ON
COMBATING DRUG ADDICTION AND THE OPIOID CRISIS 70 (2017).
120 INST. OF MED. COMM. ON OPPORTUNITIES IN DRUG ABUSE RESEARCH,
PATHWAYS OF ADDICTION: OPPORTUNITIES IN DRUG ABUSE RESEARCH
(2018); see also A Consumer's Guide to the Mental Health Parity and Addiction Equity
Act, NAT'L DISABILITY NAVIGATOR, http://www.nationaldisabilitynavigator.
org/wp-content/uploads/resources-links/SAMHSA-Parity-guide.pdf.
121 See Thomas Beaton, Health Plan cost sharing, Deductibles Outpace Members'
Wage Growth, HEALTHPAYERINTELLIGENCE (July 12, 2018), https://
healthpayerintelligence.com/news/health-plan-cost-sharing-deductibles-
outpace-members-wage-growth. See generally David Blumenthal, The Decline of
Employer-Sponsored Health Insurance, THE COMMONWEALTH FUND: TO THE
POINT (Dec. 5, 2017), https://www.commonwealthfund.org/blog/2017/
decline-employer-sponsored-health-insurance.
122 This is an oversimplification because some persons will be insured by small
group insurance, Short-Term, Limited-Duration Insurance, Association
Health Plans, grandfathered Basic Health Plans in New York and Minnesota,
and so on. However, for the purposes of this article these plans are statistically
irrelevant.
123 See Ramin Mojtabai, National Trends in Long-Term Use of Prescription Opioids, 27
PHARMACOEPIDEMIOLOGY & DRUG SAFETY 526 (2017). See also Audrey
J. Weiss et al., Opioid-Related Inpatient Stays and Emergency Department Visits
Among Patients Aged 65 Years and older, 2010 and 2015, HEALTHCARE COST
AND UTILIZATION PROJECT (Sept. 2018), https://www.ahrq.gov/news/
newsroom/press-releases/seniors-struggles-with-opioids.html.
124 CTRS. FOR MEDICARE & MEDICAID SERVS., OPIOID MISUSE STRATEGY
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Medicare provides broad access to MAT, though there are
some quirky omissions. In the words of one MAT provider, "[w]hile
Medicare pays for the pain medications that are contributing to the
OUD epidemic, it does not pay for the full range of treatment options
necessary to treat beneficiaries' addiction." 125 Indeed, one of the
greatest ironies is that Medicare covers methadone for the treatment
of pain but not for the treatment of OUD. This is because Medicare
Part D (covering prescription drugs) does not include methadone or
buprenorphine when used for treatment of opioid dependence in an
opioid treatment program (in large part this is because Part D only
applies to retail pharmacy distribution).12 6 MAT is less likely to be
covered by traditional Medicare Part C but could be covered by Part
C Medicare Advantage if they are part of a "bundled" service. 127
2. Acute Stratification on the Exchanges
After Employer-Group and Medicare insurance, stratification
increases apace. Health Insurance Marketplace plans, those
established by the ACA, 128 are sold from online marketplaces or
exchanges. The exchanges may be established and managed either
by states or, if they are unwilling, by the federal government. 129 The
policies offered on the exchanges are standardized; that is, they all
offer the same benefits. However, their premium costs differ. 13 0 The
plans often are referred to collectively as the "metallics" because
2016, 1 (2017), https://www.cms.gov/Outreach-and-Education/Outreach/
Partnerships/ Downloads/CMS-Opioid-Misuse- Strategy-2016.pdf.
125 The Opioid Crisis: Removing Barriers to Prevent and Treat Opioid Abuse and Dependence
in Medicare, Hearing Before the H. Comm. on Ways & Means, 115th Cong. 6 (2018)
(statement of Jason Kletter, President, BayMark Health Services), https://
waysandmeans.house.gov/wp-content/uploads/2018/02/20180206-HL-
Testimony-Kletter.pdf [hereinafter Kletter, Opioid Crisis].
126 See generally CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 124, at
17.
127 Kletter, Opioid Crisis, supra note 125. See generally CTRS. FOR MEDICARE
& MEDICAID SERVS., MEDICARE COVERAGE OF SUBSTANCE ABUSE
SERVICES (2016), https://www.cms.gov/Outreach-and-Education/Medicare-
Learning-Network-MLN/MLNMattersArticles/downloads/SE1604.pdf.
128 Patient Protection and Affordable Care Act § 1311(b), 42 U.S.C. § 18001
(2018).
129 See generally Patient Protection and Affordable Care Act, 42 U.S.C. §§ 18031-
41 (2018).
130 The 'Metal' Categories: Bronze, Silver, Gold & Platinum, HEALTHCARE.GOV,
https://www.healthcare.gov/choose-a-plan/plans-categories/ (last visited
Dec. 23, 2018) [hereinafter Metal Categories].
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of their gold, silver, bronze, etc., nomenclature.13 1 The plans (and
so their premiums) differ according to their actuarial value: that
"percentage of total average costs for covered benefits that a plan
will cover." 13 2
At first sight, the choice between the metallics would be
based on the level of out-of-pocket risk a person wishes to assume
and, assuming a somewhat competitive state marketplace,133 the plan
cost. However, that "simple" model becomes more complicated and
stratified because of how the ACA made premiums affordable (via
tax credits) 13 4 and reduced the impact of cost-sharing (via insurance-
company provided, but (originally) federal government financed,
subsidies) for lower income persons. 135 In general terms, persons are
eligible for financial assistance if their income is between 100% and
400% of the FPL. 136 In Medicaid expansion states, such assistance
would apply to those between <138% and 400% FPL with expanded
Medicaid picking up the cohort between 100% and 138% FPL. The
premium tax credits are calculated on the basis of a family's modified
adjusted gross income and size and apply to all of the metallics.
Cost-sharing subsidies apply only to those enrolled in their state's
131 Metal Levels for Health Insurance Plans, EHEALTH (Oct. 9, 2014), https://www.
ehealthinsurance.com/resources/affordable-care-act/metallic-health-plan-
levels; Understanding the Healthcare Exchange Plan Offering, FO RB ES (Sept.
24, 2013 8:37AM), https://www.forbes.com/sites/thesba/2013/09/24/
understanding-the-exchange-plan-offering/#7942c75f72bc; see Metal
Categories, supra note 130.
132 Glossary Definition of Actuarial Value, HEALTHCARE.Gov, https://www.
healthcare.gov/glossary/actuarial-value/ (last visited Dec 23, 2018); see, e.g.,
What's the Difference Between Bronze, Silver and Gold Plans?, BLUE CROSS BLUE
SHIELD BLUE CARE NETWORK OF MICH., https://www.bcbsm.com/index/
health-insurance-help/faqs/topics/buying-insurance/metal-tiers.html (last
visited Dec. 23, 2018).
133 See generally Cynthia Cox et al., Sizing Up Exchange Market Competition, HENRYJ.
KAISER FAM. FOUND. (Mar. 17, 2014), https://www.kff.org/health-reform/
issue-brief/sizing-up-exchange-market-competition/.
134 See generally King v. Burwell, 135 S. Ct. 2480 (2015) (holding that the ACA
authorized tax credits for health insurance purchased either from state or
federally established exchanges).
135 See generally BERNADETTE FERNANDEZ, CONG. RESEARCH SERV., HEALTH
INSURANCE PREMIUM TAX CREDITS AND COST-SHARING SUBSIDIES
(2018), https://fas.org/sgp/crs/misc/R44425.pdf.
136 "Federal poverty levels are used to determine your eligibility for certain
programs and benefits, including savings on Marketplace health insurance,
and Medicaid and CHIP coverage." Glossary Definition of Federal Poverty Level
(FPL), HEALTHCARE.Gov, https://www.healthcare.gov/glossary/federal-
poverty-level-fpl/ (last visited Dec. 23, 2018).
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"silver" plan and apply only to those between 100% (or <138% in
an expansion state) and 250% FPL. 137
Another wrinkle and potentially destabilizing occurrence was
the 2017 decision by the Trump Administration to stop making the
payments (known as Cost-Sharing Reduction Payments) to insurance
companies that compensated them for providing the cost-sharing
subsidies to their very low-income customers. 138 However, under the
ACA, insurance companies were still responsible for subsidizing the
silver plan cost-sharing by increasing the actuarial value of policies
purchased by those eligible for cost-sharing subsidies. 139 Absorbing
those costs would cause costs, and hence premiums, to rise.
Insurers' rather clever retort was to disproportionally increase the
cost of silver plans. 140 This strategy keeps non-sliver plans relatively
affordable while essentially passing on to the federal government
the increased cost of silvers plans. 141 Notwithstanding, this strategy
may increase insurance costs for the cohort that has income <400%
FPL and so lacks tax credits to offset the large premium increases. 14 2
Moreover, as the cost of exchange-based insurance for the
unsubsidized cohort rises, they are going to be far less likely to
purchase insurance, thereby reverting to uninsured status. Cost
increases and concomitant declines in the number of insured likely will
137 See Questions and Answers on the Premium Tax Credit, IRS, https://www.irs.gov/
affordable-care-act/individuals-and-families/questions-and-answers-on-the-
premium-tax-credit (last updated Mar. 16, 2018); Louise Norris, The ACA's
Cost-Sharing Subsidies, HEALTHINSURANCE.ORG (Dec. 27, 2018), https://
www.healthinsurance.org/obamacare/the-acas-cost-sharing-subsidies/.
138 Much of the (somewhat arcane) history is to be found in the now settled
litigation referred to as U.S. House of Representatives v. Price, No. 16 -5202,
2017 WL 3271445 (D.C. Cir. Aug. 1, 2017). See also Sarah Lueck, Trump Move
Would Boost Premiums, Raise Federal Costs, Destabilize Insurance Market, CTR.
ON BUDGET & POL'Y PRIORITIES (July 31, 2017, 4:30 PM), https://www.
cbpp.org/blog/trump-move-would-boost-premiums-raise-federal-costs-
destabilize-insurance-market.
139 Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 (2018).
140 Rabah Kamal et al., How the Loss of Cost-Sharing Subsidy Payments is Affecting 2018
Premiums, HENRY J. KAISER FAM. FOUND. (Oct. 27, 2017), https://www.
kff.org/health-reform/issue-brief/how-the-loss-of-cost-sharing-subsidy-
payments-is-affecting-2018-premiums/.
141 See Margot Sanger-Katz, Trump's Attack on Insurer 'Gravy Train' Could Actually
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be accelerated in 2019 with the demise of the individual mandate, 143
and the likely further destabilization of the marketplace risk pools as
the Trump Administration's favored Short-Term, Limited-Duration
Insurance14 4 and Association Health Plans ('AHPs") come online. 14s
Stratification and persistent questions about affordability
aside, marketplace plans do provide coverage for behavioral
healthcare as an EHB.614 Unfortunately, this is one point at which
the conventional wisdom that health insurance equals access to
healthcare breaks down. The problem is that insurance provides
reimbursement, not care, and so is dependent on the insurer
having adequate treatment relationships with behavioral healthcare
providers. In 2017, Stephen Melek and colleagues published a major
study examining relative access to behavioral healthcare, finding
both major disparities in the use of out-of-network providers (and
so higher-priced or non-reimbursed services) and in reimbursement
rates for behavioral healthcare providers. Specifically, the researchers
found that for the period from 2013-2015 "the proportion of
inpatient facility services for behavioral healthcare that were
provided out-of-network was 2.8 to 4.2 times higher than for
medical/surgical services, and the proportion of outpatient facility
services for behavioral healthcare that were provided out-of-network
was 3.0 to 5.8 times higher than for medical/surgical services." 147
143 See Tax Cuts and Jobs Act, Pub. L. No. 115-97, 131 Stat. 424 (2017) (codified
at I.R.C. 48 § 5000A) (reducing penalty for not having insurance to $0); see
also Christine Eibner & Sarah Nowak, The Effect of Eliminating the Individual
Mandate Penalty and the Role ofBehavioral Factors, THE COM MONWEALT H FUND
(July 11, 2018), https://www.commonwealthfund.org/publications/fund-
reports/2018/jul/eliminating-individual-mandate-penalty-behavioral-factors.
144 See generally Karen Pollitz et al., Understanding Short-Term Limited Duration Health
Insurance, HENRY J. KAISER FAM. FOUND. (Apr. 23, 2018), https://www.kff.
org/health-reform/issue-brief/understanding-short-term-limited-duration-
health-insurance/.
145 See John Arensmeyer, Association Health Plans Will Destabilize Small Group Market,
SMALL Bus. MAJORITY (June 19, 2018), http://www.smallbusinessmajority.
org/press-release/association-health-plans-will-destabilize-small-group-
market.
146 See What Marketplace Health Insurance Plans Cover, HEALTHCARE.Gov, https://
www.healthcare.gov/coverage/what-marketplace-plans-cover/ (last visited
Feb. 6, 2019).
147 STEPHEN P. MELEK ET AL., MENTAL HEALTH TREATMENT &
RESEARCH INST., ADDICTION AND MENTAL HEALTH VS. PHYSICAL
HEALTH: ANALYZING DISPARITIES IN NETWORK USE AND PROVIDER
REIMBURSEMENT RATES 1 (2017), http://www.milliman.com/
uploadedFiles/insight/2017/NQTLDisparityAnalysis.pdf.
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Regarding reimbursement, "primary care providers were paid 20.7%
to 22.0% higher rates for office visits than behavioral providers, and
medical/surgical specialty care providers were paid 17.1% to 19.1%
higher rates for office visits than behavioral providers.""14 Research
by Jane Zhu and colleagues that focused on exchange-marketplace
plans found "structural barriers" to behavioral healthcare because
approximately half of all plans featured behavioral health "narrow
networks:" networks where fewer than 25% of providers are "in-
network."14 1
The ACAs EHB requirement may not be an absolute
guarantee of affordable mental health services. Nevertheless, it does
require some services and may deliver better than that in competitive
marketplaces. Unfortunately, the Trump Administration has taken
issue with EHBs, increasing state discretion in their benchmarking. 1s0
Further, the Administration's Short-Term, Limited-Duration
Insurance and AHPs online will feature deprecated EHBs. 11 Thus,
at a time when persons suffering from OUD desperately need
coverage for behavioral health services, the Administration is
actively promoting "skimpy" policies that frequently will not include
coverage for mental health, substance use, or OUD-appropriate
prescriptions drugs.
The stratification of health insurance may (for good reason)
seem arcane, and its connection to OUD treatment somewhat
remote. However, comprehending stratification helps us understand
why there is no one solution to improving opioids treatment
interventions. Rather, each stratum requires separately tailored
improvements in the applicable insurance model because those in
different strata face different barriers. 15 2 For a start, there are those
who remain uninsured. These include undocumented persons, those
148 Id. at 2.
149 Jane M. Zhu et al., Networks in ACA Marketplaces are Narrower for Mental Health
Care Than for Primary Care, 36 HEALTH AFFAIRS 1624, 1626 (2017).
150 Patient Protection and Affordable Care Act; HHS Notice of Benefit and
Payment Parameters for 2019, 83 Fed. Reg. 16930 (Apr. 17, 2018).
151 John Arensmeyer, Association Health Plans Will Destabilize Small Group Market,
SMALL Bus. MAJORITY (June 19, 2018), http://smallbusinessmajority.org/
press-release/association-health-plans-will-destabilize-small-group-market.
See generally Karen Pollitz et al., Understanding Short-Term Limited Duration
Health Insurance, KAISER FAM. FOUND. (Apr. 23, 2018), https://www.kff.
org/health-reform/issue-brief/understanding-short-term-limited-duration-
health-insurance/.
152 See generally Kathleen Rowan et al., Access and Cost Barriers to Mental Health Care,
by Insurance Status, 1999-2010, 32 HEALTH AFF. 1723 (2013).
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who fall within the Medicaid expansion gap (100% FPL to 138%
FPL) in non-expansion states, and those with income <400% FPL
who, without tax credits, cannot afford a marketplace plan or could
not use one absent cost-sharing subsidies. Then, and more fully
described in the next section, are those who should benefit from
Medicaid or expanded Medicaid but who either are unaware of the
coverage, cannot meet the program's administrative requirements, or
(increasingly) fall afoul of new eligibility hurdles such as paperwork
or premium requirements. 15 3
Stratification based on income was intended to mitigate the
impact of poverty on access to healthcare. In actuality, it perpetuates
classism and health disparities by shuffling persons into different
healthcare systems with different coverages, expectations, and
realities. As stressors like the opioids epidemic vividly demonstrate,
a stratified system is a poor alternative to a single payer, universal
care model.
C. Medicaid's Devolution from Solution to Potential Problem
It is difficult to overestimate Medicaid's potential for
alleviating the opioid crisis. Approximately 12% of the adult Medicaid
population suffers from a SUD, 1 4 Medicaid covers nearly 40% of
nonelderly adults with OUD,15s and overall, the program funds more
than 20% of all addiction treatment."' Additionally, Medicaid offers
opportunities for innovation and states have considerable leeway
to adopt the kinds of treatments and services urgently needed by
those suffering from OUD.15s States can open up such opportunities
153 See discussion infra Section C.1.
154 Medicaid Works for People with Substance Use Disorders, CTR. ON BUDGET &
POLICY PRIORITIES (Jan. 19, 2018), https://www.cbpp.org/research/
health/medicaid-works-for-people-with-substance-use-disorders.
155 Nonelderly Adults with Opioid Addiction Covered by Medicaid Were Twice as Likely as
Those with Private Insurance or the Uninsured to Have Received Treatment in 2016,




156 Julia Zur & Jennifer Tolbert, The opioid Epidemic and Medicaid's Role in Facilitating
Access to Treatment, KAISER FAM. FOUND. (Apr. 11, 2018), http://files.kff.
org/attachment/Issue-Brief-The-Opioid-Epidemic-and-Medicaids-Role-in-
Facilitating-Access-to-Treatment.
157 U.S. DEP'T OF HEALTH & HUMAN SERVS., FACING ADDICTION IN
AMERICA: THE SURGEON GENERAL'S REPORT ON ALCOHOL, DRUGS,
AND HEALTH 6-35 to 6-38 (2016), https://addiction.surgeongeneral.gov/
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by applying to the Secretary for a Section 1115 Medicaid waiver to
use federal funds for additional services."ss Indeed, states that have
not expanded Medicaid have generally seen their percentage of
uninsured persons increase.159
Persistent insurance coverage such as that provided by
Medicaid expansion has proven very positive in improving the
management of other chronic diseases.6 0 As noted in the Surgeon
General's report, "Medicaid expansion is a key lever for expanding
access to substance use treatment because many of the most
vulnerable individuals with substance use disorders have incomes
below 138% of the federal poverty level."161 Indeed, after Kentucky
expanded Medicaid, it experienced a 700% increase in the utilization
of substance use services. 16 2
Medicaid was recognized as a key vehicle to increase the
health of near-poor adults even before the expansion of behavioral
health services by the MHPAEA and, subsequently, the ACA. From
2001, the Bush Administration's Health Insurance Flexibility and
Accountability initiative encouraged states to request Section 1115
waivers in an attempt to provide coverage (albeit constrained by
budget neutrality) to persons <200% FPL. 16 3
Originally, even before the ACA, Section 1115 demonstration
projects often were used to reduce stratification. 164 The ACA itself
sites/default/files/surgeon-generals-report.pdf.
158 42 U.S.C. § 1315 (2018) (originally enacted by the Social Security Act of 1962,
the waiver provision even predated Medicaid).
159 Jennifer Haley et al., Adults' Uninsurance Rates Increased by 2018, Especially in
States That Did Not Expand Medicaid, HEALTH AFF. BLOG (Sept. 26, 2018),
https://www.healthaffairs.org/do/10.1377/hblog20180924.928969/full/.
160 See, e.g., Rebecca Myerson et al., Medicaid Eligibility Expansions May Address Gaps
in Access to Diabetes Medications, 37 HEALTH AF F. 1200 (2018).
161 U.S. DEP'T OF HEALTH & HUMAN SERVS., supra note 68, at 6-7.
162 Substance Use and the ACA in Kentucky, FOUND. FOR A HEALTHY Ky. 7, 7
(2016), https://www.healthy-ky.org/res/images/resources/Full-Substance-
Use-Brief-Final_12_16-002-.pdf.
163 See generally Hefei Wen et al., Effect of Medicaid Expansions on Health Insurance
Coverage and Access to Care among Low Income Adults with Behavioral Health
Conditions, 50 HEALTH SERVS. RES. 1787 (2015).
164 NAT'L CONFERENCE OF STATE LEGISLATURES, UNDERSTANDING
MEDICAID SECTION 1115 WAIVERS: A PRIMER FOR STATE LEGISLATORS
4 (2017), http://www.ncsl.org/Portals/1/Documents/Health/Medicaid_
WaiversState_31797.pdf; THE KAISER COMM'N ON MEDICAID AND THE
UNINSURED, A LOOK AT SECTION 1115 MEDICAID DEMONSTRATION
WAIVERS UNDER THE ACA: A Focus ON CHILDLESS ADULTS 4 (2013),
https://kaiserfamilyfoundation.files.wordpress.com/2013/10/8499-a-look-
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signaled considerable interest in that model by permitting more
ambitious projects under an additional waiver process."'s Overall,
Section 1115 waivers could help in implementing state innovations
in behavioral health such as suspending the Institutions for Mental
Diseases exclusion, 166 reimbursing care coordination, or paying for
services that address health-related social needs such as supportive
housing, transportation, and food. 16 7
1. Regressive Trends in Section 1115 Waivers
During the Obama Administration, the waiver process
continued much as before until Medicaid expansion stalled
because states with conservative administrations declined to opt-
in to expansion. 16 The Administration then took a detour from
traditionally approved waivers and began approving requests that
appealed to generally-held conservative views on health policy.
In particular, the Administration allowed waivers that required
enrollees to have some "skin in the game;" 161 for example, by
paying small premiums, contributing to health savings accounts, or
requiring healthy/wellness behaviors.
At least two objections can be levelled at these Obama-era
waivers. First, there are serious doubts about the effectiveness
at-section-1115-medicaid-demonstration-waivers.pdf; see, e.g., Background on
Oregon's 1115 Medicaid Demonstration Waiver, OR. HEALTH AUTH., https://
www.oregon.gov/oha/HSD/Medicaid-Policy/Pages/Background.aspx (last
visited Dec. 18, 2018).
165 See Patient Protection and Affordable Care Act § 1332, 42 U.S.C. § 18052
(2018).
166 Social Security Act § 1905(a) (B), 42 U.S.C. § 1396(d) (2018) (prohibiting
Medicaid financing for behavioral care provided in residential treatment
facilities with more than 16 beds); see discussion infra notes 215-18.
167 See NAT'L Ass'N OF MEDICAID DIR., MEDICAID SECTION 1115 WAIVER
TRENDS IN AN ERA OF STATE FLEXIBILITY (2018), http://medicaiddirectors.
org/wp-content/uploads/2018/03/Section-1 15-Waiver-Trends-NAMD-
Whitepaper- 1.pdf.
168 See generally Where the States Stand on Medicaid Expansion, ADVISORY BD. (June
8, 2018), https://www.advisory.com/daily-briefing/resources/primers/
medicaidmap; Sara Rosenbaum, The Trump Administration Re-Imagines Section
1115 Medicaid Demonstrations - and Medicaid, HEALTH AFF. BLOG, (Nov. 9,
2017), https://www.healthaffairs.org/do/10.1377/hblog20171109.297738/
full/.
169 See Seema Verma & Brian Neale, Health Indiana 2.0 is Challenging Medicaid
Norms, HEALTH AFF. BLOG (Aug. 29, 2016), https://www.healthaffairs.org/
do/10.1377/hblog20160829.056228/full/.
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of "skin-in-the-game" and wellness initiatives. 170 Second, some
of the approved provisions were likely to decrease enrollment or
service utilization. Because this was a likely result, the Obama
Administration likely considered these to be worthy trade-offs
in order to make headway in states reticent to expand Medicaid.
Equally, conservative-led states could expand Medicaid with a
modicum of political cover; what Abbe Gluck and Nicole Huberfeld
call the "secret boyfriend model" of federalism.71
An example of a "skin-in-the-game" waiver is found in
Indiana's "Healthy Indiana Plan 2.0."172 Under this waiver, Medicaid
benefits were tiered; the higher tier included vision and dental
coverage and did not impose a co-pay for most services. 173 To qualify
for this higher tier, otherwise-eligible persons had to contribute
to a health savings account. Failure to make contributions (or
never signing up) had a differential impact depending whether
the otherwise-eligible person was in the traditional Medicaid or
expanded cohort. In broad terms, failure to contribute would move
those at 100% FPL or below to the lower benefits tier, while those in
the expanded > 138% FPL cohort would not receive those additional
benefits, or if they stopped paying would be locked out of benefits for
a period of time.7 Analysis of HIP 2.0 has shown that 55% of those
eligible to pay premiums failed to do so, either dropping down to the
lower benefits tier (< 101% FPL) or never being enrolled or losing
coverage (> 100% FPL). 171 "The top two reasons cited by people
who never enrolled in or lost HIP 2.0 coverage were affordability
170 See generally JANE B. WISHNER ET AL., THE URBAN INST., MEDICAID




171 Abbe R. Gluck & Nicole Huberfeld, What is Federalism in Healthcare for?, 70
STAN. L. REV. 1689, 1767 (2018).
172 Letter from Marilyn Tavenner, Dep't of Health & Human Serv., to Joseph Moser,
Medicaid Dir. for Ind. Family and Soc. Serv. Admin. (Jan. 27, 2015), https://
www.in.gov/fssa/hip/files/IN _HIP_2.0_CMS Approval_Ltr_1_27_15.pdf.
173 ROBIN RUDOWITZ ET AL., KAISER FAM. FOUND., DIGGING INTO
THE DATA: WHAT CAN WE LEARN FROM THE STATE EVALUATION OF
HEALTHY INDIANA (HIP 2.0) PREMIUMS 3 (2018), http://files.kff.org/
attachment/Issue-Brief-Digging-Into-the-Data-What-Can-We-Learn-from-
the-State-Evaluation-of-Healthy-Indiana-HIP-20-Premiums.
174 Id. at 2.
175 Id. at 3.
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and confusion about the payment process." 176
Overall, the results from these Obama-era waiver approvals
undoubtedly show net gains in the number of covered persons.177
However, the picture seems cloudier with regard to the behavioral
health cohort. The Indiana Medicaid population is approximately
1.3 million.178 Approximately 100,000 (or 7%) suffer from SUD,
although under-reporting makes it likely that the number is roughly
twice that (or 14%).179 It seems arguable that programs that lead
with paperwork and not treatment will have a disproportionately
negative impact on those needing behavioral health services. Either
Medicaid eligibility paperwork will not be completed or the staff in
emergency rooms or other treatment situations will find themselves
pausing from their clinical responsibilities to help fill in forms.
Clearly, the Trump Administration is doubling down
on the approach to Section 1115 waivers taken by the Obama
Administration. First, it is approving draconian provisions, such
as work requirements, that the prior administration rejected. 1s0
Second, while the Obama Administration used Section 1115 waivers
as a carrot offered to states vacillating over expansion, the Trump
Administration is using the waiver process to reform traditional
Medicaid.' There is, therefore, more going on here than simply
176 Id. at 4.
177 See, e.g., Seth Freedman et al., Learning from Waiver States: Coverage Effects Under
Indiana's HIP Medicaid Expansion, 37 HEALTH AFF. 936, 939-40 (2018).
178 See Medicaid in Indiana, KAISER FAMILY FOUND. (Nov. 2018), http://files.
kff.org/attachment/fact-sheet-medicaid-state-IN (providing the statistic
that 20% of Indiana's population is on Medicaid, which is approximately 1.3
million).
179 NICOLAS P. TERRY ET AL., LEGAL AND POLICY BEST PRACTICES IN
RESPONSE TO THE SUBSTANCE ABUSE CRISIS 32 (2018), https://
grandchallenges.iu.edu/doc/iu-grand-challenges-legal-and-policy-best-
practices.pdf.
180 See, e.g., Michael Ollove, Should Medicaid Recipients Have to Work?, PEW (Sept.
30, 2015), https://www.pewtrusts.org/en/research-and-analysis/blogs/
stateline/2015/09/30/should-medicaid-recipients-have-to-work; Mattie
Quinn, On Medicaid, States Won't Take Feds' No for an Answer, GOVERNING
(Oct. 11, 2016), http://www.governing.com/topics/health-human-services/
gov-medicaid-waivers-arizona-ohio-cms.html; Sara Rosenbaum, The Trump
Administration Re-Imagines Section 1115 Medicaid Demonstrations - and Medicaid,
HEALTH AFF. BLOG (Nov. 9, 2017), https://www.healthaffairs.org/
do/10. 1377/hblog2Ol71109.297738/full/.
181 MARYBETH MUSUMECI ET AL., SECTION 1115MEDICAID DEMONSTRATION
WAIVERS 3-5 (2018), http://files.kff.org/attachment/Issue-Brief-Section-
1115-Medicaid-Demonstration-Waivers-The-Current-Landscape-of-
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approving more conservative waivers or providing political cover for
the most conservative states to expand Medicaid. Rather, it indicates
a major shift in philosophy regarding Medicaid.
In 2017, this was laid bare in just the third paragraph of a
letter to the country's governors from then-HHS Secretary Tom Price
and CMS Administrator Seema Verma (hereinafter the "Price-Verma
letter"). Whether conscious or not of their historical revisionism,
they wrote, "[t] he expansion of Medicaid through the [ACA] to non-
disabled, working-age adults without dependent children was a clear
departure from the core, historical mission of the program." 18 2 It was
in this letter that the new Administration also announced its belief
that "[t] he best way to improve the long-term health of low-income
Americans is to empower them with skills and employment." 18 3
In January 2018, then-CMS Director Brian Neale provided more
details in a letter to state Medicaid directors (hereinafter the "Neale
letter").18
Predictably, states with conservative leadership applied for
new waivers or added work requirements to requests for renewal
of existing waivers-that cohort exemplified by Indiana, Kentucky,
and Ohio, states that have been hit particularly hard by the opioid
epidemic. 18 Both the Price-Verma and the Neale letters reflected on
Approved-and-Pending-Waivers.
182 Letter from Thomas E. Price, Sec'y, U.S. Dep't of Health & Human
Servs., and Seema Verma, Adm'r, Ctrs. for Medicare & Medicaid Servs.,
to U.S. State Governors 1 (March 14, 2017), https://www.hhs.gov/sites/
default/files/sec-price-admin-verma-ltr.pdf [hereinafter Price-Verma Letter].
183 Id.
184 Letter from Brian Neale, Medicaid Deputy Adm'r & Dir., Ctrs. for Medicare
& Medicaid Servs., to State Medicaid Dirs. (Jan. 11, 2018), https://www.
medicaid.gov/federal-policy-guidance/downloads/smdl8002.pdf; see also
Marian Jarlenski et al., Shaping Health Policy for Low-Income Populations: An
Assessment of Public Comments in a New Medicaid Waiver Process, 42 J. HEALTH
POL., POL'Y, & L. 1039, 1047 (2017) (examining whether the comment
letters used the rhetoric of "personal responsibility," "consumer choice," or
"consumer-driven care" rather than "vulnerable populations").
185 Indiana Opioid Summary, NAT'L INST. ON DRUG ABUSE (Feb. 2018), https://
www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state/
indiana-opioid-summary; Billy Wynne & Taylor Cowey, State Waivers as a
National Policy Lever, HEALTH AFF. BLOG (Feb. 6, 2018), https://www.
healthaffairs.org/do/10.1377/hblog20180202.543483/full/; see, e.g., Kyle
Fee, The OpioidEpidemicandItsEffects, FED. RES. BANK CLEVELAND (May 31,
2018), https://www.clevelandfed.org/newsroom-and-events/publications/
community-development-briefs/db-20 18053 1-the-opioid-epidemic. aspx; see
Where the States Stand on Medicaid Expansion, ADVISORY BOARD (Nov. 5, 2018,
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the opioid epidemic. While the former included language pledging
CMS's cooperation with the states to provide a "full continuum of
care,""' the Neale letter included a promise of carve-outs from the
work requirements for those with SUD. These included required
respect for civil rights protections and "counting time spent in medical
treatment towards an individual's work/community engagement
requirements."1 17 However, whether compliance with the Americans
with Disabilities Act ('ADA"), 18 and some requirement that states
use some kind of "medical frailty" safe harbor, 189 will be sufficient
protections for those with OUD remains an open question.
Again, to use Indiana's Medicaid as an example, the state's
2018 waiver extension includes additional potential barriers to
Medicaid enrollment. For example, the extension approves a
tobacco surcharge, a work requirement (beginning in 2019), and
more process requirements. 10 Persons with OUD likely will have
difficulty meeting the accompanying administrative requirements.
Many may be transients whose qualifying paperwork fails to reach
them,191 and others cycle in and out of relapse, 192 making regular
12:51 PM), https://www.advisory.com/daily-briefing/resources/primers/
medicaidmap.
186 Price-Verma Letter, supra note 182, at 3.
187 Letter from Brian Neale, supra note 184, at 6.
188 Title II of the ADA protects qualified individuals with disabilities from
discrimination on the basis of disability from services, programs, or activities
provided by state and local government entities. A person with OUD may be
a "qualified individual with a disability." 28 C.ER. § 35.130 (2018).
189 MARYBETH MUSUMECI ET AL., APPROVED CHANGES IN INDIANA'S
SECTION 1115 MEDICAID WAIVER EXTENSION 5 (2018), http://files.kff.
org/attachment/Issue-Brief-Approved-Changes-in-Indianas-Section- 1115-
Medicaid-Waiver-Extension.
190 Letter from Demetrios Kouzoukas, Principal Deputy Adm'r, Ctrs. for
Medicare & Medicaid Servs., to Allison Taylor, Medicaid Dir., Indiana
Family & Soc. Servs. Admin. (Feb. 1, 2018), https://www.medicaid.gov/
Medicaid-CHIP-Program-Information/By-Topics/Waivers/i 115/downloads
/in/Healthy-Indiana-Plan-2/in-healthy-indiana-plan-support-20-ca.pdf. See
generally MUSUMECI ET AL., supra note 189, at 1.
191 SUZANNE WIKLE, MEDICAID WORKS: No WORK REQUIREMENT
NECESSARY 6 (2018), https://www.clasp.org/sites/default/files/
Medicaid%20Works-No%20Work%20Requirement%20Necessary%20
updated%20December%202018%20final.pdf; see also Lydia Coutr6, Ohio
Hospitals Battle Proposed Medicaid Work Requirements, MODERN HEALTHCARE
(Apr. 30, 2018), https://www.modernhealthcare.com/article/20180430/
NEWS/180439992.
192 NIH NIDA actually defines drug abuse and addiction as a "relapsing brain
disease." See The Science of Drug Use and Addiction, NAT'L INST. ON DRUG
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employment problematic. The new program will be subject to the
ADA, containing a SUD-exception from the work requirement, and
a medical frailty care exception to lockout.193 However, it is unclear
how these will operate and precisely how substantiation burdens will
fall on those with SUD. It is at least arguable that these additional
requirements will increase the barriers to healthcare among the poor
and near-poor in Indiana, and disproportionately impact persons
with OUD.1 14 While the proportion of those with SUD or OUD is
not broken out, new figures from Arkansas, which has imposed
an 80-hour-per-month work requirement, suggest that thousands
of persons are at risk of being dropped from the state's Medicaid
program.Is
If the worst-case scenario plays out with those needing
behavioral health services excluded because of a politically-
motivated work requirement, the irony will be cruel. Expanding
Medicaid should be one of the most effective interventions in the
OUD epidemic, extending healthcare to a particularly hard-hit
demographic. However, the price for that intervention, a Medicaid
expansion "tax," may create new barriers to eligibility for large
numbers in the very cohort that needs help. These waivers or waiver
extensions are adding increased premiums, work requirements,
documentation burdens, and requirements that recipients log onto
state computer systems to report employment details; failure to
comply with even the minutest requirements leads to lockouts.196
ABUSE (July 2018), https://www.drugabuse.gov/publications/media-guide/
science-drug-use-addiction-basics.
193 MUSUMECI ET AL., supra note 189, at 4, 8.
194 HANNAH KATCH ET AL., TAKING MEDICAID COVERAGE AWAY FROM
PEOPLE NOT MEETING WORK REQUIREMENTS WILL REDUCE Low-
INCOME FAMILIES' ACCESS TO CARE AND WORSEN HEALTH OUTCOMES
(2018), https://www.cbpp.org/sites/default/files/atoms/files/2-8-18health2.
pdf.
195 Erin Brantley & Leighton Ku, Arkansas's Early Experience with Work Requirements
Signals Larger Losses to Come, THE COMMONWEALTH FUND: TO THE POINT
(Oct. 31, 2018), https://www.commonwealthfund.org/blog/2018/arkansas-
early-experience-work-requirements; Jessie Hellmann, Arkansas Medicaid
Work Requirements Could Cost Thousands Coverage, Data Show, THE HILL (Aug.
15, 2018), https://thehill.com/policy/healthcare/401975-new-data-shows-
arkansass-medicaid-work-requirements-could-cost-thousands; see also Jessica
Greene, Medicaid Recipients' Early Experience with the Arkansas Medicaid Work
Requirement, HEALTH AFF. BLOG (Sept. 5, 2018), https://www.healthaffairs.
org/do/10. 1377/hblog2o180904.979085/full/.
196 See generally MUSUMECI ET AL., supra note 189.
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There is particular potential for additional "churn" as those with
OUD drop in and out of these programs with complex administrative
or work requirements.1 17 It is at least arguable that those types
of conditions for eligibility would disproportionally harm those
with OUD. Many with OUD will likely be unable to handle the
administrative burdens and simply walk away.
Re-architecting the Medicaid program around employment
is flawed on a number of fronts. First, the policy shift likely is not
worth the administrative costs; only a very small number of Medicaid
eligible persons who could work choose not to."' Sixty percent work
and most of those who don't are disabled, caregivers, or in school.'
Only seven percent would qualify as not-working and there are
many reasons, including lack of jobs in a particular locale, which
could explain some of that number.20 0 Second, the CMS explanation
for a work requirement is based on some twisted logic. While it is
true that those who are employed generally have better health, it is
false to conclude that making people work will increase their health.
As Douglas Jacobs observes, "it could just as easily be that poor
health causes unemployment" while research suggests "that having
Medicaid made it easier to look for a job." 2 01
At present, the impact of imposing work requirements
is uncertain. Some programs do not begin until 2019 and the
legality of the waivers is under attack. For example, in Stewart v.
Azar, Medicaid enrollees challenged the section 1115 waiver CMS
granted to Kentucky HEALTH which included a work requirement,
premiums, additional cost-sharing, and a coverage lockout for failure
197 RACHEL GARFIELD ET AL., IMPLICATIONS OF WORK REQUIREMENTS
IN MEDICAID 5 (2018), http://files.kff.org/attachment/Issue-Brief-
Implications-of-Work-Requirements-in-Medicaid-What-Does-the-Data-
Say; see also Letter from Demetrios Kouzoukas, supra note 190. See generally
MUSUMECI ET AL., supra note 189.





201 Douglas Jacobs, The Social Determinants Speak: Medicaid Work Requirements Will
Worsen Health, HEALTH AFF. BLOG (Aug. 6, 2018), https://www.healthaffairs.
org/do/10.1377/hblog20180730.371424/full/; see also LARISA ANTONISSE &
RACHEL GARFIELD, THE RELATIONSHIP BETWEEN WORK AND HEALTH
(2018), http://files.kff.org/attachment/Issue-Brief-The-Relationship-
Between-Work-and-Health-Findings-from-a-Literature%20Review.
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to promptly renew.20 2 Kentucky itself admitted that almost 100,000
Kentuckians would lose coverage.203 In June 2018, the federal district
court decided that the Secretary's waiver decision was arbitrary and
capricious because he failed to consider the impact of the waiver
policies on insuring people (Medicaid's primary purpose) given the
estimate of how many would lose coverage.20 4 Undoubtedly, neither
the litigation nor the question of obstructive Medicaid restrictions
are over, and reports suggest that CMS is not inclined to change its
new embrace of work requirements.20 5 On a brighter note, there are
indications that an increasing number of non-expansion states are
now leaning toward expansion 206 and, as a result, a net increase in
the number of insureds. However, it is unclear how many of these
recent converts to expansion will have to adopt draconian conditions
to cement the transition.2 07 Nor, as already discussed, is it clear
whether those "skin-in-the-game" policies and work requirements
will disproportionally impact those needing behavioral health
services.
2. Medicaid Reimbursement for Behavioral Health
Services
For those needing behavioral health services the stakes
are high. Those covered by Medicaid are twice as likely as those
who are uninsured or have private insurance to receive treatment
for OUD and almost three times more likely to have received
outpatient treatment.2 08 Overall, Medicaid provides access to more
202 Stewart v. Azar, 313 E Supp. 3d 237, 248 (D.D.C. 2018).
203 Id. at 263.
204 Id. at 259-62; see MARYBETH MUSUMECI, EXPLAINING Stewart v. Azar
(2018), http://files.kff.org/attachment/Issue-Brief-Explaining-Stewart-v-
Azar-Implications-of-the-Courts-Decision-on-Kentuckys-Medicaid-Waiver.
205 See Dan Diamond & Rachana Pradhan, CMS Plots Path Forward for Kentucky
Work Requirements After Court Setback, POLITICO (July 18, 2018), https://www.
politico.com/story/2018/07/18/kentucky-medicaid-work-requirements-cms-
court-setback-694575.
206 Donald Moulds et al., A New Group of States Looks to Expand Medicaid, THE
COMMONWEALTH FUND: TO THE POINT (Aug. 27, 2018), https://www.
commonwealthfund.org/blog/2018/states-look-expand-medicaid.
207 See generally id.
208 Julia Zur & Jennifer Tolbert, The opioid Epidemic and Medicaid's Role in Facilitating
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comprehensive behavioral health services than marketplace plans.2 09
However, while states generally are obliged to provide such services
writ large, not all states provide robust services. 2 10 Three variables
are at work here: first, the extent to which a state provides different
modes of treatment; second, the levels of care that are available; and
third, the extent to which an individual state has taken advantage
of additional coverages (for example, Health Homes) or requested
waivers under Section 1115 to address issues that go beyond
mainstream clinical care (for example, wraparound services).
While Medicaid (courtesy of the MHPAEA and ACA) requires
states to include reimbursement for substance use treatment, it did
not require all three forms of MAT until the 2018 opioid legislation.2 11
While a majority of states do require such reimbursements, many still
do not, the omission frequently being methadone-based treatment,
which is absent from numerous state plans.2 12
Medicaid has approved the ASAM guidelines providing
the appropriate levels of care. 2 13 However, yet again, there are
considerable state-by-state disparities in the availability of these
levels of care under Medicaid. Particular deficiencies are identified
in levels 3 (residential inpatient services) and 4 (intensive inpatient
209 Medicaid Works for People with Substance Use Disorders, CTR. ON BUDGET &
POL'Y PRIORITIES (Jan. 19, 2018), https://www.cbpp.org/research/health/
medicaid-works-for-people-with-substance-use-disorders.
210 See id.
211 See MEDICAID INNOVATION ACCELERATOR PROGRAM, OVERVIEW OF
SUBSTANCE USE DISORDER (SUD) CARE CLINICAL GUIDELINES: A
RESOURCE FOR STATES DEVELOPING SUD DELIVERY SYSTEM REFORMS
1 (2017), https://www.medicaid.gov/state-resource-center/innovation-
accelerator-program/iap-downloads/reducing-substance-use-disorders/
asam-resource-guide.pdf; see also Insurance and Payments, SUBSTANCE ABUSE
& MENTAL HEALTH SERV. ADMIN., https://www.samhsa.gov/medication-
assisted-treatment/treatment/insurance-payments (last updated Sept. 28,
2015); SUPPORT for Patients and Communities Act, Pub. L. No. 115-271, §
2001 (2018).
212 Colleen M. Grogan et al., Survey Highlights Differences in Medicaid Coverage for
Substance Use Treatment and Opioid Use Disorder Medications, 25 HEALTH AFF.
2289, 2292 (2016); States Reporting Medicaid Coverage of Medication Assisted
Treatment (MAT) Drugs, THE HENRY J. KAISER FAM. FOUND., https://www.
kff.org/medicaid/state-indicator/states-reporting-medicaid-coverage-of-
medication-assisted-treatment-mat-drugs/ (last visited Dec. 14, 2018).
213 See Letter from Vikki Wachino, Dir., Ctrs. for Medicare & Medicaid Servs.,
to State Medicaid Dirs. 7 (July 27, 2015), https://www.medicaid.gov/federal-
policy-guidance/downloads/SMD 15003.pdf; see also MEDICAID INNOVATION
ACCELERATOR PROGRAM, supra note 211, at 2-3.
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services), along with other state-by-state variations such as pre-
authorization requirements and coverage limitations.214
The relative lack of level 3 residential inpatient care is to a
large extent because of what is known as the Institutions for Mental
Disease ("IMD") exclusion that applies to reimbursement for adults
aged 21-64.215 As should be obvious from its name, the IMD exclusion
is a relic from the past, prior to the integration of behavioral health
services with general medical care. IMDs are hospitals or treatment
facilities that have more than 16 beds and that primarily provide
mental health or substance use care.2 16 Increasingly, CMS seems
willing to approve Section 1115 waivers to the IMD prohibition
and allow Medicaid reimbursement 217 while recent federal opioid
legislation brought about the exclusion's suspension but not its
ultimate demise.218
Section 1115 waivers are the one part of the third aspect of
Medicaid treatment; the potential to reimburse for and so unlock
expanded behavioral health services. The other key route for states
is to adopt "state plan amendments." One of these, included in the
ACA, 2 19 is the Medicaid "health home" that provides time-limited
federal funding for creating "homes" for beneficiaries that provide
case management, care coordination, and other services that would
be of particular utility when dealing with those requiring behavioral
health services. Approximately 15 states have adopted some form of
this model.2 20
In contrast, Section 1115 waiver applications are being
adopted broadly to increase reimbursable behavioral health
214 Grogan et al., supra note 212, at 2292.
215 42 U.S.C. § 1396d(a) (29) (B) (2018).
216 See generally MaryBeth Musumeci, Key Questions about Medicaid Payment for
Services in "Institutions for Mental Disease," THE HENRYJ. KAISER FAM. FOUND.
(June 18, 2018), https://www.kff.org/medicaid/issue-brief/key-questions-
about-medicaid-payment-for-services-in-institutions-for-mental-disease/.
217 See Letter from Brian Neale, Dir., Ctrs. for Medicare & Medicaid Servs., to
State Medicaid Dirs. 2 (Nov. 1, 2017), https://www.thenationalcouncil.org/
wp-content/uploads/2017/1 1/smd- 17-003.pdf.
218 SUPPORT for Patients and Communities Act, Pub. L. No. 115-271, §§ 1012-
13, 5052, 132 Stat. 3894, 69-70 (2018).
219 See 42 U.S.C. § 256a-1 etseq. (2018).
220 KATHYMOSES & BRIANNAENSSLIN, CTR. FOR HEALTH CARE STRATEGIES,
SEIZING THE OPPORTUNITY: EARLY MEDICAID HEALTH HOME LESSONS
1 (2014).
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services. 2 2 1 This route has been encouraged by both the Obama 22 2
and Trump Administrations.2 2 3 In addition to IMD waivers (the
most popular), a large number of states have applied for waivers
to expand community-based services (such as supportive housing
or peer coaching), increase the eligible cohort, or finance delivery
system reforms (such as integrating services).224 However, these
demonstration projects must be budget neutral,22 5 which likely
creates difficult decisions for states as they increase their behavioral
health services (for example, calibrating the appropriate balance of
spending on institutional versus community-based care).
As Jonathan Oberlander has commented, " [t] he ACA is stuck
in purgatory, beyond comprehensive repeal but subject to a war of
attrition that jeopardizes its gains."2 26 Medicaid expansion, a major
component in improving behavioral health services, continues to be
under threat, potentially leading to the loss of some or all insurance
for hundreds of thousands of persons with behavioral health
issues. 22 7 The worst case scenario is that even traditional Medicaid
may be cut back if reformers succeed in moving "welfare" programs
to a block grant model.2 28
221 MaryBeth Musumeci et al., Section 1115 Medicaid Demonstration Waivers: The
Current Landscape of Approved and Pending Waivers, THE HENRY J. KAISER FAM.
FOUND. (Sept. 20, 2018), https://www.kff.org/medicaid/issue-brief/key-
questions-about-medicaid-payment-for-services-in-institutions-for-mental-
disease/.
222 See Letter from Vikki Wachino to State Medicaid Dirs., supra note 213, at 4
(replaced by Nov. 1, 2017 letter below).
223 See Letter from Brian Neale to State Medicaid Dirs., supra note 217, at 1.
224 MARYBETH MUSUMECI, THE HENRY J. KAISER FAMILY FOUND., KEY
THEMES IN MEDICAID SECTION 1115 BEHAVIORAL HEALTH WAIVERS 2
(2017).
225 Letter from Timothy B. Hill, Acting Dir., Ctrs. for Medicare & Medicaid Servs.,
to State Medicaid Dirs. 1-2 (Aug. 22, 2018), https://www.medicaid.gov/
federal-policy-guidance/downloads/smd 18009.pdf.
226 Jonathan Oberlander, The Republican War on Obamacare - What Has It Achieved?,
379 NEw ENG. J. MED. 703, 705 (2018).
227 Peggy Bailey, ACA Repeal WouldJeopardize Treatmentfor Millions with Substance Use
Disorders, Including opioid Addiction, CTR. ON BUDGET & POL'Y PRIORITIES
(Feb. 9, 2017), https://www.cbpp.org/research/health/aca-repeal-would-
jeopardize-treatment-for-millions-with-substance-use-disorders; Richard
G. Frank & Sherry A. Glied, Keep Obamacare to Keep Progress on Treating Opioid
Disorders and Mental Illnesses, THE HILL (Jan. 11, 2017), http://thehill.com/
blogs/pundits-blog/healthcare/3 136 72-keep-obamacare-to-keep-progress-
on-treating-opioid-disorders.
228 See Aaron E. Carroll, How Would Republican Plansfor Medicaid Block Grants Actually
Work?, N.Y. TIMES (Feb. 6, 2017), https://www.nytimes.com/2017/02/06/
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Assuming the survival of Medicaid and expanded Medicaid,
the practical challenge will be to minimize the impact of "skin-in-
the-game" work requirements and increased administrative burdens
that will disproportionally have a negative impact on those needing
behavioral health services. Philosophically and politically, the greater
challenge will be to reverse the current Administration's "welfare"
labelling of these important programs. As Sara Rosenbaum noted
regarding the Price-Verma letter's rollout of work requirements
and the Administration's new objectives, "[iun all of this there is
absolutely no mention of Medicaid as insurance. "229
D. Differential Architectures, Fragmentation, and a Paucity of
Wraparound Services
From the early days of addiction science, those with SUD
were viewed as "morally flawed and lacking in willpower . . .
which led to an emphasis on punishment rather than prevention
and treatment. "230 Not surprisingly, behavioral and non-behavioral
health services developed with differential architectures implicating,
inter alia, treatment models, places for care, and data sharing.
Deinstitutionalization began decades ago while, more recently,
the MHPAEA and the ACA strengthened the integration or
mainstreaming of treatments for substance use disorder and mental
illness. However, in yet another example of path dependency, the
practices and structures of the past haunt the present. The stigma
surrounding SUD and mental illness remains as an intermediary
determinant of health for those with OUD, while access and
treatment differentials play out as structural determinants because
patients and providers struggle with fragmentation and lack of care
coordination. These flaws in the provision of behavioral healthcare
services are amplified by fragmentation problems in healthcare
generally and the lack of investment in case management, care




229 Sara Rosenbaum, The Trump Administration Re-Imagines Section 1115 Medicaid
Demonstrations - And Medicaid, HEALTH AFFAIRS (Nov. 9, 2017), https://
www.healthaffairs.org/do/10.1377/hblog20171109.297738/full/.
230 NAT'L INST. ON DRUG ABUSE, DRUGS, BRAINS, AND BEHAVIOR:
THE SCIENCE OF ADDICTION 2 (2018), https://www.drugabuse.gov/
publications/drugs-brains-behavior-science-addiction/preface.
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To a large extent, lack of care coordination or fragmentation
of care are defining features of the U.S. healthcare system. 23 1 The
need for improved coordination frequently has been cited by
organizations such as the National Academies of Science,2 32 the
Agency for Healthcare Research and Quality,233 and the National
Quality Forum.234
Successful care coordination has several key pillars, including
"access to a range of health care services and providers," effective
communications and care plan transitions (hand-offs) between
providers, a focus on the patient's needs, the communication of
"clear and simple information that patients can understand," 23 5 and
the effective use ofhealth information technologies. 236 Demonstration
projects have identified cost-savings in the Medicaid program from
the use of care coordination interventions for those with chronic
conditions.2 37
1. Fragmentation and the Continuum of Care for Those
with OUD
It is broadly recognized that many of the care coordination
issues that present in the OUD context follow from the historic
segregation of substance use diagnosis and treatment from
mainstream healthcare delivery, with the former frequently thought
of as social or criminal justice issues that should be dealt with by
psychiatric hospitals or prisons. 238 As we now recognize, persons
231 See, e.g., FAMILIES USA, THE PROMISE OF CARE COORDINATION:
TRANSFORMING HEALTH CARE DELIVERY 3 (2013).
232 See, e.g., THE NAT'L ACADS. OF ScIS., IMPROVING DIAGNOSIS IN HEALTH
CARE 6-9 (2015).
233 Care Coordination, AGENCY FOR HEALTHCARE RES. & QUALITY, https://www.
ahrq.gov/professionals/prevention-chronic-care/improve/coordination/
index.html (last visited Dec. 14, 2018).
234 Care Coordination Measures, NAT'L QUALITY FORUM, http://www.qualityforum.
org/ProjectDescription.aspx?projectlD=73700 (last visited Dec. 14, 2018).
235 What Is Care Coordination?, NEJM CATALYST (Jan. 1, 2017), https://catalyst.
nejm.org/what-is-care-coordination/.
236 Improved Care Coordination: The Need for Better Improved Care Coordination,
HEALTHIT.Gov, https://www.healthit.gov/providers-professionals/
improved-care-coordination (last visited Dec. 14, 2018).
237 See, e.g., Jingping Xing et al. Care Coordination Program for Washington State
Medicaid Enrollees Reduced Inpatient Hospital Costs, 34 HEALTH AF F. 653 (2015).
238 U.S. DEP'T OF HEALTH & HUMAN SERVS., FACING ADDICTION IN
AMERICA: THE SURGEON GENERAL'S REPORT ON ALCOHOL, DRUGS,
AND HEALTH 1-19, 6-5 (2016).
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suffering from OUD are particularly vulnerable populations that in
practice require high levels of care coordination. These cohorts also
need a well-thought-out continuum of care such that harm reduction
or emergency department interventions can lead to treatment or,
later, that treatment can lead to recovery services.23 9
The insurance policy stratification discussed above relates
primarily to access to care, including the near-zero access experienced
by the uninsured and the differential levels of care available to
cohorts insured within different strata. Fragmentation is less about
access and more about the quality of care that is delivered. Of
course, those flaws overlap. For example, facilities being detox-only
or not offering a full range of evidence-based medication assisted
treatments 240 exhibit aspects relating both to access and quality.
Similarly, the absence of a progressive continuum of care not only
frustrates clinical interventions but also other innovative programs.
For example, researchers found that, while an innovative police-led
referral program 241 proved effective in referring persons to short-
term services, it could not "overcome a fragmented treatment system
focused on acute episodic care which remains a barrier to long-term
recovery." 24 2
Behavioral healthcare frustrates clinical interventions by
placing limitations on the number of treatment options at a time
when the opposite is required. As already discussed, Medicaid
previously maintained an IMD exclusion, prohibiting Medicaid
payments for some residential programs. 243  There are also
limitations on the number of OTPs that are the requisite location
for most MAT treatments.24 4 By law, OTPs must be accredited
239 See P. Todd Korthius et al., Primary Care-Based Models for the Treatment of opioid
Use Disorder, 166 ANNALS INTERNAL MED. 268, 276 (2017).
240 Hannah K. Knudsen et al., Barriers to the Implementation of Medication-Assisted
Treatment for Substance Use Disorders: The Importance of Funding Policies and Medical
Infrastructure, 34 EVALUATION & PROGRAM PLAN. 375, 375-76, 379 (2011),
https://doi.org/10.1016/j.evalprogplan.2011.02.004. See also Brendan Saloner
& Colleen L. Barry, Ending the Opioid Epidemic Requires a Historic Investment in
Medication-Assisted Treatment, 37 J. POL. ANALYSIS & MGMT. 431 (2018).
241 Police Assisted Addiction & Recovery Initiative, https://paariusa.org/ (last visited
Sept. 28, 2018).
242 Davida M. Schiff et al., A Police-Led Addiction Treatment Referral Program in
Gloucester, MA: Implementation and Participants' Experiences, 82 J. SUBSTANCE
ABUSE TREATMENT 41, 41 (2017).
243 See supra text accompanying notes 215-18.
244 Medication and Counseling Treatment, SUBSTANCE ABUSE & MENTAL HEALTH
SERVS. ADMIN., U.S. DEP'T. OF HEALTH & HUMAN SERVS., https://www.
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by an approved accrediting body and certified by SAMHSA.245
The regulatory model is designed to ensure that medications are
accompanied by appropriate "counseling and behavioral therapies,
to provide a 'whole-patient' approach to the treatment of substance
use disorders." 246 Additionally, and with specific applicability to
agonists, the regulatory model is intended to prevent diversion.2 47
An exception applies to the partial agonist buprenorphine, through
the waiver structure introduced by the Drug Addiction Treatment
Act of 2000.248 Although that waiver program increased the number
of physicians permitted to prescribe buprenorphine, it also placed
somewhat arbitrary limits on the numbers of patients that physicians
with waivers are permitted to treat.24 9
Those suffering from OUD face a sadly limited view of the
continuum of care. For example, there is strong evidence syringe
exchange programs open a path to treatment, do not increase rates
of addiction, 25 0 and reduce the risk of needle stick injuries among
law enforcement officers in the community.25 1 Syringe exchange
samhsa.gov/medication-assisted-treatment/treatment (last updated Sept. 28,
2015); see also SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN.,
U.S. DEP'T. OF HEALTH & HUMAN SERVS., FEDERAL GUIDELINES FOR
OPIOID TREATMENT PROGRAMS 4 (2015), http://mpcmh.org/wpcontent/
uploads/ 2017/12/SAMHSAGuidelinesOpiod-Treatment-Programs.pdf.
245 Opioid Treatment Program Certification, 42 C.ER. § 8.11 (2018).
246 Medication-Assisted Treatment (MAT), SUBSTANCE ABUSE & MENTAL HEALTH
SERVS. ADMIN., U.S. DEP'T. OF HEALTH & HUM. SERVS., https://www.
samhsa.gov/medication-assisted-treatment (last updated Sept. 28, 2015).
247 FEDERAL GUIDELINES FOR OPIOID TREATMENT PROGRAMS, supra note
244.
248 DEA Requirements for DATA Waived Physicians (DWPs), D.E.A. DIVERSION
CONTROL Div., U.S. DEP'T. OF JUSTICE, https://www.deadiversion.usdoj.
gov/pubs/docs/dwp buprenorphine.htm (last visited Dec. 16, 2018).
249 See generally Andrea G. Barthwell et al., What's in a Number? Recommending
Practicality in the Data 2000 Patient Limits, 12 J. OPIOID MGMT. 243 (2016).
A situation that was somewhat improved by the 2018 opioid legislation. See
SUPPORT for Patients and Communities Act, Pub. L. No. 115-271, § 3201(a)
(2018).
250 Steffanie A. Strathdee et al., Needle-Exchange Attendance and Health Care Utilization
Promote Entry into Detoxification, 76 J. URB. HEALTH 448 (1999), https://www.
ncbi.nlm.nih.gov/pubmed/10609594; see also INST. OF MED., NAT'L ACAD.
OF SCI., PREVENTING HIV INFECTION AMONG INJECTING DRUG USERS
IN HIGH-RISK COUNTRIES: AN ASSESSMENT OF THE EVIDENCE 141
(2006), https://www.nap.edu/read/11731/chapter/6#140.
251 Samuel L. Groseclose et al., Impact ofIncreased Legal Access to Needles and Syringes
on Practices ofInjecting-Drug Users and Police Officers - Connecticut, 1992-1993, 10 J.
ACQUIRED IMMUNE DEFICIENCY SYNDROMES & HUM. RETROVIROL 82,
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programs are safe places and a place of re-entry from the streets
for those with OUD. They offer persons with OUD a route to a
safer life, the minimization of comorbidities such as HIV/AIDS or
Hepatitis-C, treatment, and even recovery,252 suggesting they should
be more formally recognized as part of the continuum of care.253
Similarly, emergency department treatment should be recognized as
a step toward treatment or at least chronic disease management.2 5 4
As noted by Mark Olfson and colleagues, "[t]he high and broadly
distributed mortality risks after nonfatal opioid overdose underscore
the importance of coordinating medical, substance use, and mental
health management after opioid overdose."255
2. Non-Aligned Data Protection Models
Healthcare data enjoy exceptional protection under
federal law when compared to data in other domains. 256 Some
data in healthcare subdomains experience even greater degrees of
protection; these include the exceptional protection for process
notes taken by psychotherapists 2 57 and the Genetic Information
Nondiscrimination Act of 2008's prohibitions on the acquisition of
genetic information. 2 58 Arguably, the strongest protection given to
any healthcare data is that applied to behavioral health information
by the Confidentiality of Substance Use Disorder Patient Records
86-88 (1995).
252 ELIZABETH TAYLOR, AIDS FOUND., AIDS WATCH: SYRINGE EXCHANGE
PROGRAMS (2015), https://www.aidsunited.org/data/ files/Site_18/
AW2015Syringe ExchangeWeb.pdf.
253 See Michael Kidorf et al., Benefits of Concurrent Syringe Exchange and Substance
Abuse Treatment Participation, 40 J. SUBSTANCE ABUSE TREATMENT 265
(2011), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056913/ (users of
syringe exchange programs also participating in any type of substance abuse
treatment reported less drug use).
254 See Andrew Herring, Addiction Treatment Comes to the Emergency Department,
CAL. HEALTH CARE FOUND. (May 17, 2018), https://www.chcf.org/blog/
addiction-treatment-comes-to-the-emergency-department/. See generally
Gail D'Onofrio et al., Emergency Department-Initiated Buprenorphine/Naloxone
Treatment for Opioid Dependence: A Randomized Clinical Trial, 313 JAMA 1636
(2015).
255 Mark Olfson et al., Causes of Death After Nonfatal Opioid Overdose, 75 JAMA
PSYCHIATRY 821, 821 (2018).
256 See generally Nicolas Terry, Regulatory Disruption and Arbitrage in Healthcare Data
Protection, 17 YALE J. HEALTH POL'Y L. & ETHICS 143, 162-71 (2017).
257 45 C.ER. §§ 164.501, 164.508(a) (2) (2018).
258 45 C.ER. § 164.502(a) (5) (i) (2018).
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rule, often referred to as 42 C.ER. Part 2 (or just "Part 2").259
The federal Health Insurance Portability and Accountability
Act of 1996 ("HIPAA") Privacy Rule applies to patient data in
most traditional healthcare environments. 26 0 As a result, HIPAA
privacy applies to patients being treated for substance use or other
mental health issues. 26 1 HIPAA permits broad data-sharing between
providers without requiring any patient consent.2 62 The Privacy Rule
does not contain any provisions specific to substance use patients.
However, Part 2 provides an additional layer of confidentiality
for the records of SUD (and therefore OUD) patients.26 3 Part 2
applies to federally-assisted programs that provide SUD programs
to diagnosis, treat, or refer. Part 2 can apply to personnel or a unit
contained within a general medical facility.26 4 Most importantly, Part
2 has required an additional, highly specific consent from the patient
before SUD records may be shared.265
In 2017, SAMHSA updated Part 2 including some changes to
the consent process. 266 The updated consent provisions allow for a
limited "general" consent contained in the "To Whom" section of the
consent, under which a SUD patient may designate certain providers
to receive certain, specified SUD information.26 7 Technically, the
259 42 C.ER. pt. 2 (2018). See generally LAURA ASHPOLE ET AL., 42 C.F.R. PART 2
IN RETROSPECTIVE: THE 30-YEARJOURNEY OF THE ALCOHOL AND DRUG
ABUSE TREATMENT CONFIDENTIALITY REGULATIONS (2017), https://
www.healthlawyers.org/Members/PracticeGroups/TaskForces/BH/briefings/
Documents/42_CFRPart2_MB.pdf.
260 45 C.ER. §§ 160, 162, 164 (2018). In general, the HIPAA rules apply to
"covered entities," including most doctors, hospitals, and treatment facilities.
Covered Entities and Business Associates, U.S. DEP'T OF HEALTH & HUMAN
SERVS., https://www.hhs.gov/hipaa/for-professionals/covered-entities/
index.html (last visited June 16, 2017).
261 45 C.ER. § 164.501 (2018).
262 45 C.ER. § 164.506 (2018).
263 Susan Awad, Confused by Confidentiality? A Primer on 42 CFR Part 2, AM.
SOC. OF ADDICTION MED. (Aug. 15, 2013), https://www.asam.org/
resources/publications/magazine/read/article/2013/08/15/confused-by-
confidentiality-a-primer-on-42-cfr-part-2.
264 42 C.ER. § 2.11 (2018).
265 42 C.ER. § 2.3 1 (2018). See generally Substance Abuse Confidentiality Regulations,
SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., U.S. DEP'T. OF
HEALTH & HUMAN SERVS., https://www.samhsa.gov/about-us/who-we-
are/laws-regulations/confidentiality-regulations-faqs (last updated May 1,
2018).
266 Confidentiality of Substance Use Disorder Patient Records, 82 Fed. Reg. 6052
(Jan. 18, 2017).
267 42 C.ER. §§ 2.31, 2.33 (2018).
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new consent rules operate quite differently from HIPAA and bring
with them distinct accountability, research, and other provisions.
Although the updated disclosure rule does include a new "medical
emergency" exception, 26 8 even that is not as permissive as the
equivalent HIPAA approach. In 2018, SAMHSA revisited some of
these issues but again declined to further align HIPAA and Part 2
provisions. 26 9
There has been a consistent drumbeat to better align these two
sets of privacy regulations. For example, The President's Commission
on Combating Drug Addiction and The Opioid Crisis recommended
action to "[b]etter align, through regulation, patient privacy laws
specific to addiction with the Health Insurance Portability and
Accountability Act (HIPAA) to ensure that information about SUDs
be made available to medical professionals treating and prescribing
medication to a patient." 27 0
The differential approach to protecting SUD records is blamed
for inadequate integration of full SUD patient data in electronic
health records, the exclusion of SUD records from statewide sharing
through Health Information Exchanges, the perpetuation of stigma
by treating SUD patients differently, and the exclusion of SUD
patients from potentially beneficial research based on electronic
health records data.2 7 1
Continued data segregation has been justified on the grounds
that such data are particularly sensitive and that there has been a
history of discrimination against SUD patients.2 72 For example, The
268 42 C.ER. § 2.51 (2018).
269 Confidentiality of Substance Use Disorder Patient Records, 83 Fed. Reg. 239,
241 (Jan. 3, 2018).
270 OFFICE OF NAT'L DRUG CONTROL POLICY, THE PRESIDENT'S
COMMISSION ON COMBATING DRUG ADDICTION AND THE OPIOID
CRISIS FINAL REPORT 210 (2017), https://www.whitehouse.gov/sites/
whitehouse.gov/files/images/FinalReportDraft_11-15-2017.pdf; see also
Letter from Rebecca Murow Klein, Chair, P'ship to Amend 42 CFR Part 2,
to Orrin Hatch, Chairman, U.S. Senate Comm. on Fin., and Ron Wyden,
Ranking Member, U.S. Senate Comm. on Fin. (Feb. 16, 2018), http://www.
helpendopioidcrisis.org/wp-content/uploads/2018/02/Partnership-to-
Amend-42-CFR-Part-2-Recommendations.pdf.
271 See Austin B. Frakt & Nicholas Bagley, Protection or Harm? Suppressing Substance-
Use Data, 372 NEw ENG. J. OF MED. 1879 (2015).
272 U.S. DEP'T OF HEALTH & HUMAN SERVS., FACING ADDICTION IN
AMERICA: THE SURGEON GENERAL'S REPORT ON ALCOHOL, DRUGS,
AND HEALTH 6-1, 6-33 to 6-34 (2016), https://addiction.surgeongeneral.
gov/sites/default/files/surgeon-generals-report.pdf.
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Surgeon General's Report noted, " [c] urrently, persons with substance
use disorders involving illicit drugs are not protected under anti-
discrimination laws, such as the ADA." 2 73 This is partially correct;
although SUD is recognized by the ADA as a disability, protection is
lost if the person is "currently engaging in the illegal use of drugs."274
As noted by SAMHSA, disclosure of SUD information can lead to a
host of negative consequences, "including: [loss of employment,
loss of housing, loss of child custody . .. discrimination by medical
professionals and even arrest, prosecution, and incarceration."275
It is arguable that those seeking behavioral health services are less
concerned about data sharing between providers but particularly
fearful of information about their illness being shared with law
enforcement and corrections.
An overarching policy imperative is to normalize or
mainstream the treatment of SUD. However, if our healthcare
delivery is to move to a position where SUD is treated as a mainstream
disease, then segregation of data between SUD populations and
other populations must be better managed. There is a very real
safety angle here; for example, there is some evidence that patients
with a substance use history unknown to treating physicians have
been put at risk by opioid prescribing.27 6
This is not a newly identified problem and there have been
unsuccessful attempts to pass legislation to provide regulatory
authority to better align the rules.2 77 As HHS rolls out regulations
and policies authorized under the 21st Century Cures Act to
273 Id. at 6-34.
274 42 U.S.C. § 12114(a) (2018); see also 42 U.S.C. § 12111(6) (2018).
275 Confidentiality of Substance Use Disorder Patient Records, 82 Fed. Reg. 6052,
6053 (Jan. 18, 2017); see Paul N. Samuels & Patty McCarthy Metcalf, Relaxing
Patient Privacy Rules Would Worsen the opioid Epidemic, STAT NEWS (Nov. 24,
2017), https://www.statnews.com/2017/11/24/opioid-epidemic-patient-
privacy/ (presenting strong defenses of Part 2); see also Karla Lopez & Deborah
Reid, Discrimination Against Patients with Substance Use Disorders Remains Prevalent
and Harmful: The Case for 42 CFR Part 2, HEALTH AFF. BLOG (Apr. 13, 2017),
https://www.healthaffairs.org/do/10. 1377/hblog2o170413.059618/full/.
276 See Constance M. Weisner et al., Trends in Prescribed Opioid Therapy for Non-Cancer
Pain for Individuals with Prior Substance Use Disorders, 145 PAIN 287 (2009).
277 See, e.g., Overdose Prevention and Patient Safety Act of 2017, H.R. 3545,
115th Cong. (2017); Helping Families in Mental Health Crisis Act of 2016,
H.R. 2646, 114th Cong. (2016).
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promote interoperability,278 discourage "information blocking," 2 79
and establish a Trusted Exchange Framework, 28 0 more and improved
clinical sharing inevitably will result and may, in the future, lead to
some consensus on how to proceed with the differential laws.
HHS's Office of Civil Rights has published FAQs encouraging
sharing 28 1 and, more recently, issued a "clarifying" Opioid Crisis
Guidance that notes the flexibility in the HIPAA rule that permits
providers to disclose information to families in dangerous or
emergency situations and the fact that a patient's personal
representative (recognized as such by state law) has the same
rights as the patient.2 82 However, the Guidance does not address
the relationship between HIPAA and the more stringent Part 2.283
Equally, SAMHSA has issued a FAQ on the interrelationship of
Part 2 and the Health Information Exchange.2 84 This dichotomous
approach is clearly insufficient.
Although the House of Representatives' version of the
2018 opioid legislation would have amended Part 2's enabling
legislation 285 to permit the sharing of SUD records with other
treatment providers, as permitted under the HIPAA Privacy Rule,286
278 42 U.S.C. § 300jj (2018). See generally Don Rucker, Achieving the Interoperability
Promise of 21st Century Cures, HEALTH AFF. BLOG (June 19, 2018), https://
www.healthaffairs.org/do/10.1377/hblog20180618.138568/full/.
279 42 U.S.C. § 300jj-52(a)-(b) (2018).
280 THE OFFICE OF THE NAT'L COORDINATOR FOR HEALTH INFO. TECH.,
DRAFT TRUSTED EXCHANGE FRAMEWORK (2018), https://www.healthit.
gov/sites/default/files/draft-trusted-exchange-framework.pdf.
281 FAQ: Disclosures to Family and Friends, HHS.Gov, https://www.hhs.gov/hipaa/
for-professionals/faq/disclosures-to-family-and-friends/index.html (last
visited Dec. 15, 2018).
282 HHS Office for Civil Rights Issues Guidance on How HIPAA Allows Information Sharing




284 LEGAL ACTION CTR. FOR THE SUBSTANCE ABUSE & MENTAL
HEALTH SERVS. ADMIN., U.S. DEP'T OF HEALTH & HUMAN SERVS.,
FREQUENTLY ASKED QUESTIONS: APPLYING THE SUBSTANCE ABUSE
CONFIDENTIALITY REGULATIONS TO HEALTH INFORMATION EXCHANGE
(HIE) (2010), https://www.samhsa.gov/sites/default/files/faqs-applying-
confidentiality-regulations-to-hie.pdf.
285 42 U.S.C. § 290dd-2 (2018).
286 Overdose Prevention and Patient Safety Act, H.R. 6082, 115th Cong. (2018).
See generally Mary Butler, House of Representatives Passes Privacy Law Updates
Governing Opioid Abuse Treatment, J. OF AHIMA (June 20, 2018), http://
journal.ahima.org/2018/06/20/house-of-representatives-passes-privacy-law-
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that provision did not survive reconciliation and was omitted from
the final legislation.2 87 Separately, however, on July 26, 2018, HHS
Deputy Secretary Hargan tweeted that the agency would soon be
issuing Requests for Information on HIPAA and Part 2 and would
be "taking regulatory action,"288 a position confirmed by Secretary
Azar.289
From harm reduction through treatment and recovery
services, together with the accompanying patient data, there
needs to be a more global sense of how to improve and coordinate
behavioral health services. States need to improve case management,
increase the availability of peer coaches, and invest in wrapround
services, either through direct service improvements or by incenting
stakeholders such as Medicaid managed care providers to step up.
The ASAM levels of care discussed above 29 0 should be seen as an
important baseline but one to which harm reduction and long-term
recovery should be added.
V. The Healthcare Wasteland: Jails and Prisons
I think we are in rats' alley
Where the dead men lost their bones.291
More than half of state prisoners and two-thirds of sentenced
jail inmates meet the diagnostic criteria for SUD.292 A quarter of
inmates suffer from both SUD and a co-occurring mental health
updates-governing-opioid-abuse-treatment/.
287 SUPPORT for Patients and Communities Act, H.R. 6, 115th Cong. (2018).
288 Eric D. Hargan (@DepSecHargan), TWITTER (Jul. 26, 2018, 1:05 PM),
https://twitter.com/DepSecHargan/status/1022573758475849728.
289 Alex M. Azar II, Sec'y, U.S. Dep't of Health & Human Servs., Remarks to the
Heritage Foundation (July 26, 2018), https://www.hhs.gov/about/leadership/
secretary/speeches/20 18-speeches/remarks-to-the-heritage-foundation.
html.
290 See supra text accompanying note 52.
291 T.S. ELIOT, THE WASTE LAND (1922).
292 JENNIFER BRONSON ET AL., U.S. DEP'T OF JUSTICE, DRUG USE,
DEPENDENCE, AND ABUSE AMONG STATE PRISONERS AND JAIL
INMATES, 2007-2009 1 (2017), https://www.bjs.gov/content/pub/pdf/
dudaspji0709.pdf; THE NAT'L CTR. ON ADDICTION & SUBSTANCE
ABUSE AT COLUMBIA UNIV., BEHIND BARS II: SUBSTANCE ABUSE AND
AMERICA'S PRISON POPULATION 3 (2010), https://www.centeronaddiction.
org/addiction-research/reports/behind-bars-ii-substance-abuse-and-
america%E2%80%99s-prison-population.
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problem.29 3 It has been estimated that between a quarter and a
third of those who suffer from heroin addiction pass through the
corrections system each year.294 Ironically, however, the criminal
justice system is the place where the medicalization of substance
use is least likely to be endorsed.29 5 Worse, the criminal justice
system frequently embraces the very opposite of the policy needed
to address the opioid epidemic by criminalizing those who need
behavioral healthcare services. Just as the Penrose hypothesis played
out, 296 transforming our corrections facilities into a makeshift mental
health system,29 7 so now the cycle has repeated as prisons and jails
now also house a significant population of those with SUD.
A. The State ofJails and Prisons
Fewer than 30 of the nation's 5,100 jails and prisons offer
methadone or buprenorphine-based MAT.298 This is despite the
evidence that those treatments result in significant reduction in
293 THE NAT'L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA
UNIV., supra note 292, at 3. See generally Roger H. Peters et al., Co-Occurring
Substance Use and Mental Disorders in The Criminal Justice System: A New Frontier of
Clinical Practice and Research, 38 PSYCHIATRIC REHABILITATION J. 1 (2015)
(discussing the prevalence of substance use disorders among prison inmates
with mental disorders than those without a mental disorder).
294 Amy E. Boutwell et al., Arrested on Heroin: A National Opportunity, 3 J. OF
OPIOID MGMT. 328, 328 (2007).
295 See How People with Opioid Addictions are Treated in Prison, NPR (Aug. 30,
2018), https://www.npr.org/2018/08/30/643445817/how-people-with-
opioid-addictions-are-treated-in-prison; see also Erin Schumaker, Inadequate
Prison Policies Put Former Inmates at Greater Risk of Opioid Death, HUFFINGTON
POST (July 31, 2018) https://www.huffingtonpost.com/entry/inadequate-
prison-policies-put-former-inmates-at-greater-risk-of-opioid-death_
us 5b58e0c9e4b0bl5aba94c3b6.
296 L.S. Penrose, Mental Disease and Crime: Outline of a Comparative Study of European
Statistics, 18 BRITISH J. MED. PSYCHOL. 1 (1939). The hypothesis is that
there is an inverse relationship between a country's available psychiatric beds
and its prison population. See, e.g., Mark Toynbee, The Penrose Hypothesis in the
21st Century: Revisiting theAsylum, 18 EVIDENCE-BASED MENTAL HEALTH 76
(2015).
297 Samantha Raphelson, How the Loss of U.S. Psychiatric Hospitals Led to a
Mental Health Crisis, NPR (Nov. 30, 2017, 1:15 PM), https://www.npr.
org/20 17/11/30/567477160/how-the-loss-of-u-s-psychiatric-hospitals-led-
to-a-mental-health-crisis.
298 Timothy Williams, Opioid Users Are FillingJails, Why Don't Jails Treat Them?, N.Y.
TIMES (Aug. 4, 2017), https://www.nytimes.com/2017/08/04/us/heroin-
addiction-jails-methadone-suboxone-treatment.html.
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post-release overdoses or deaths 299 and decreased recidivism.3 00
According to Redonna Chandler and colleagues, "the criminal justice
system provides a unique opportunity to intervene and disrupt the
cycle of drug use and crime in a cost-effective manner," however
they also recognize that "[t]he challenge of delivering treatment in
a criminal setting requires the cooperation and coordination of 2
disparate cultures: the criminal justice system organized to punish
the offender and protect society and the drug abuse treatment
systems organized to help the addicted individual."3 01
That last reason aside, there are several explanations for
the low rate of utilization of MAT in the criminal justice system.
In jails the stays are, or should be, brief-rendering effective
treatment questionable. However, jails do offer an opportunity for
screening and referral to treatment. The situation in prisons is more
complicated, with cost issues,3 02 multiple levels of stigma,3 03 and an
institutional culture that is oppositional to the use and potential
diversion of agonist or partial agonist drugs.304
Nevertheless, methadone treatment has been successfully
employed at Rikers Island in New York City for 30 years, resulting
in "overall health care cost savings, reduced crime and recidivism,
reduced HIV and hepatitis C transmission, and better than average
rates of recovery from drug use." 3 05 A similar success story has
299 John Marsden et al., Does Exposure to Opioid Substitution Treatment in Prison
Reduce the Risk of Death After Release? A National Prospective Observational Study in
England, 112 ADDICTION 1408, 1415 (2017).
300 Vincent Tomasino et al., The Key Extended Entry Program (KEEP): A Methadone
Treatment Program for Opiate-Dependent Inmates, 68 MOUNT SINAI J. MED. 14,
19-20 (2001).
301 Redonna K. Chandler, et al., Treating Drug Abuse and Addiction in the Criminal
Justice System: Improving Public Health and Safety, 301 JAMA 183, 189-90 (2009)
(citation omitted).
302 An issue not limited to SUD. See, e.g., Adam Beckman et al., Follow California's
Lead: Treat Inmates with Hepatitis C, HEALTHAFFAIRS (July 24, 2018), https://
www.healthaffairs.org/do/10. 1377/hblog20180724.396136/full/?.
303 German Lopez, How America's Prisons are Fueling the Opioid Epidemic,
Vox (Mar. 26, 2018, 9:20 AM), https://www.vox.com/policy-and-
politics/2018/3/13/17020002/prison-opioid-epidemic-medications-
addiction.
304 Leah Pope et al., A New Normal: Addressing Opioid Use Through the Criminal Justice
System, VERA INST. JUST., https://www.vera.org/publicationdownloads/
new-normal-opioid-use-criminal-justice-system/new-normal-opioid-use-
criminal-justice-system.pdf (last visited Sept. 28, 2018).
305 Christine Vestal, At Rikers Island, a Legacy of Medication-Assisted Opioid Treatment,
PEW (May 23, 2016), http://www.pewtrusts.org/en/research-and-analysis/
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been reported from the Rhode Island Department of Corrections;3 06
a unified prison/jail system that uses all three forms of MAT that
extends the continuum of care such that individuals who are on
MAT at intake are not tapered and, upon reentry, connect treated
individuals to community-based resources.3 07
Notwithstanding these successes, at least "28 [states] don't
fully offer any medication to prisoners with opioid use disorders."3 08
It is hardly surprising, therefore, that there are examples of persons
suffering from a diagnosable and diagnosed disease, but who have
been denied the accepted standard of care, who have then sought
legal redress.3 09 The courts have adopted a high bar for Eighth
Amendment inadequate treatment claims, "medical indifference,"
that requires the showing of not only medical malpractice but also
animus.310
Therefore, as jurisprudence stands today, Title II of the
ADA311 may be a better vehicle for bringing actions against jails
and prisons for inadequate OUD treatment. For example, the U.S.
Attorney's office in Massachusetts has initiated an investigation of
the Massachusetts Department of Corrections for discontinuing
MAT upon incarceration.3 12 A lawsuit filed by the American Civil
Liberties Union of Washington State against Whatcom County Jail
in Bellingham, Washington goes further, arguing that prisoners
blogs/stateline/2016/05/23/at-rikers-island-a-legacy-of-medication-assisted-
opioid-treatment.
306 Andrew Joseph, One State Takes a Novel Approach to Opioid Addiction: Access
to Treatment for All Inmates, STAT (Aug. 3, 2017), https://www.statnews.
com/2017/08/03/opioid-treatment-prisons/.
307 Traci C. Green et al., Postincarceration Fatal Overdoses After Implementing
Medications for Addiction Treatment in a Statewide Correctional System, 75 JAMA
PSYCHIATRY 405, 405-407 (2018).
308 Lopez, supra note 303.
309 See, e.g., Gallegos v. Bemarlillo Cty. Bd. of Comm'rs, No. CIV 16-0127 JB/
WPL, 2017 WL 3575883, *1-2 (D. N.M. Aug. 17, 2017); Niemic v. UMass
Corr. Health, 89 E Supp. 3d 193, 198-99 (D. Mass. 2015).
310 See, e.g., Helling v. McKinney, 509 U.S. 25, 30-35 (1993); Estelle v. Gamble,
429 U.S. 97, 103-107 (1976); cf Brown v. Plata, 563 U.S. 493, 510 (2011)
(allowing prisoner release after showing of overcrowding and systemic failures
related to medical treatment).
311 42 U.S.C. § 12131; 28 C.ER pt. 35 (2018) (protecting individuals with
disabilities from discrimination on the basis of disability regarding services,
programs, and activities provided by State and local government entities).
312 Letter from U.S. Att'y Gen., Dist. of Mass., to Mass. Exec. Office of Pub. Safety
& Sec., Gen. Counsel, and Mass. Exec. Office of Health & Human Servs., Gen.
Counsel (Mar. 16, 2018).
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should be treated with opiate-withdrawal medication rather than
being required to go "cold turkey."313
B. Reentry andAvoiding Recidivism
According to the National Center on Addiction and Substance
Abuse, "[r]eleased inmates are more than three times likelier
than the general population to meet clinical criteria for substance
abuse,"314 while "[o]ver half (52.2 percent) of substance-involved
inmates have one or more previous incarcerations compared with
31.2 percent of inmates who are not substance involved." 3 15 More
specifically, with regard to OUD, and according to German Lopez,
" [s]ince so few state prisons offer adequate access to treatment, the
days and weeks after a person's release from prison are perhaps the
single deadliest time period in the US's opioid epidemic." 316 Huge
numbers of our fellow citizens are therefore trapped in a cycle of
imprisonment, untreated OUD, and reincarceration. Many die
shortly after release, with one study finding, "[d]uring the first 2
weeks after release, the risk of death among former inmates was
12.7 times that among other state residents."3 17
This does not have to be the case even in corrections facilities
that are opposed to agonists. For example, a pilot study found that
treating prisoners with extended-release naltrexone just prior to
reentry from jail was associated with significantly lower rates of
opioid relapse. 3 18 The negative structural determinants go beyond
the availability of treatment. The social determinants are equally
negative, with released inmates highlighting "the significance of
313 Gene Johnson, Lawsuit: Washington Jail Must Provide Addiction Treatment, U.S.
NEWS & WORLD REP. (June 7, 2018, 7:53 PM), https://www.usnews.com/
news/best-states/washington/articles/2018-06-07/lawsuit-washington-jail-
must-provide-addiction-treatment.
314 NAT'L CTR. ON ADDICTION AND SUBSTANCE ABUSE AT COLUM. UNIV.,
supra note 292, at 59.
315 Id. at 5.
316 Lopez, supra note 303.
317 Ingrid A. Binswanger et al., Release from Prison - A High Risk of Death for Former
Inmates, 356 NEw ENG. J. MED. 157, 161 (2007).
318 Joshua D. Lee et al., Opioid Treatment at Release from Jail Using Extended-Release
Naltrexone: A PilotProof-of-Concept Randomized Effectiveness Trial, 110 ADDICTION
1008, 1012 (2015); cf. Aaron D. Fox et al., Release from Incarceration, Relapse to
Opioid Use and the Potential for Buprenorphine Maintenance Treatment: A Qualitative
Study of the Perceptions of Former Inmates with Opioid Use Disorder, 10 ADDICTION
SCI. & CLINICAL PRAC. 2 (Jan. 2015) (reporting multiple factors behind
prisoners refusing buprenorphine upon release).
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poor social support, medical problems, and inadequate financial
resources to support" re-integration while they simultaneously faced
"ubiquitous exposure to drugs in the neighborhoods to which they
were released."319 There are very few wraparound services that aid
prisoner reentry by, for example, assisting with serious issues such
as employment and housing,3 2 0 while failure to acquire post-release
employment is associated with poverty and recidivism.321
VI. Conclusion
"Between 2001 and 2016, the number of opioid-related
deaths in the United States increased by 345% . . . 33.3 to 130.7
deaths per million population;" a public health crisis particularly
responsible for the premature deaths of young and middle-aged
adults.32 2 Estimates suggest that opioids could be responsible for
another half million drug-related deaths during the next decade,3 23
becoming this generation's AIDS epidemic, 324 and likely even
exceeding its death toll.3 25
Both our current healthcare system and the opioid epidemic
deserve to be labelled as wicked problems. In both scenarios we are
appropriately warned that wicked problems resist unitary diagnosis
or single solutions. 326 Although the epidemic is national in its scope,
in the end, the greatest toll of the opioid epidemic likely will fall
319 Ingrid A Binswanger et al., Return to Drug Use and Overdose After Release from
Prison: A Qualitative Study of Risk and Protective Factors, 7 ADDICTION ScI. &
CLINICAL PRAC. 3 (2012) (small qualitative study using semi-structured
interviews).
320 See generally Faith E. Lutze et al., Homelessness and Reentry: A Multisite Outcome
Evaluation of Washington State's Reentry Housing Program for High Risk Offenders,
41 CRIM. JUST. & BEHAV. 471 (2014).
321 Adam Looney & Nicholas Turner, Work and Opportunity Before and After
Incarceration, BROOKINGS INST. (Mar. 2018), https://www.brookings.edu/
wp-content/uploads/2018/03/es_20180314_looneyincarcerationfinal.pdf.
322 Tara Gomes et al., The Burden of Opioid-Related Mortality in the United States, 1
JAMA NETWORK OPEN, June 2018, at 1.
323 Max Blau, STAT Forecast: Opioids could Kill Nearly 500,000 Americans in the Next
Decade, STAT (June 27, 2017), https://www.statnews.com/2017/06/27/
opioid-deaths-forecast/.
324 Andrew Sullivan, The Opioid Epidemic is This Generation's AIDS Crisis, N.Y. MAG.
(Mar. 16, 2017), http://nymag.com/daily/intelligencer/2017/03/the-opioid-
epidemic-is-this-generations-aids-crisis.html.
325 Carol Levine, The Statistics Don't Capture the Opioid Epidemic's Impact on children,
STAT (Jan. 2, 2018), https://www.statnews.com/2018/01/02/opioid-
epidemic-impact-children/.
326 Lee, supra note 36, at 51.
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disproportionately on the Midwestern and Southern states that
exhibit poverty, marginalized populations, poor social determinants
of health, underfunded public health, and limited access to
healthcare.32 7
Starting from the hypothesis that many of the barriers to
effective interventions in the opioid crisis are properties of our
deficient health access and delivery processes, it is not difficult
to suggest some relevant flaws that rise to the level of structural
determinants: access and benefit stratification, the changing role of
Medicaid, problems associated with fragmentation of care (the lack
of behavioral health services integrated into our primary care systems
cannot be overemphasized), and the lack of wraparound services.
It is not necessary that we all end up agreeing that healthcare is a
major cause; that "It's the Healthcare, Stupid!" However, what we
should all be able to agree on is that we will have to re-engineer our
healthcare system if we wish to make any headway against this or
future addictions crises.
327 Tobacco Nation: The Deadly State of Smoking Disparity in the U.S., TRUTH
INITIATIVE, https://truthinitiative.org/sites/default/files/Tobacco-Nation-
FINAL.pdf (last visited Dec. 17, 2018).
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